Disorders of optic nerve and visual pathways

H7_OPTNERVE

optic neuritis: Optic neuritis is inflammation of the optic nerve, the nerve that carries the visual signal from the eye to the brain.The conditionmay cause sudden, reduced vision in the affected eye(s). While the cause of optic neuritis is unknown, it has been associated with autoimmune diseases, infections, multiple sclerosis , drug toxicity and deficiency of vitamin B-12. Vision often returns to normal within 2-3 weeks without treatment. In some cases, corticosteroids are given to speed recovery. If known, the underlying cause should be treated.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H46-H48 Cause of death: ICD-10 — H46-H48 2 out of 7 registries used, show all original rules.	3773
4. Check minimum number of events None	3773
5. Include endpoints H7_OPTNEURITIS H7_OPTNEUROTH H7_RETROBULBNEURINOTH H7_OPTNERVPATHINOTH	4088
6. Filter based on genotype QC (FinnGen only)	3912

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	H7_OPTNERVE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_OPTNEURITIS\|H7_OPTNEUROTH\|H7_RETROBULBNEURINOTH\|H7_OPTNERVPATHINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H4[6-8]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H4[6-8]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of optic nerve and visual pathways based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27317	15860	11283
Only index persons	24341	14506	9835
Unadjusted period prevalence (%)
Whole population	0.40	0.45	0.32
Only index persons	0.47	0.53	0.38
Median age at first event (years)
Whole population	42.35	40.11	45.40
Only index persons	41.50	39.25	44.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3912	2555	1357
Unadjusted period prevalence (%)	0.81	0.91	0.62
Median age at first event (years)	45.90	41.13	54.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4088: Matched controls
40880

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AA31

ATC

[U] teriflunomide

61.6

318.7

177

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

10.9

307.7

493

508

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

6.4

307.7

918

1762

G93.2

ICD-10 Finland

Benign intracranial hypertension

117.0

307.7

211

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

37.6

307.7

297

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.9

307.7

652

1096

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

71.5

307.7

666

111

L03AX13

ATC

glatiramer acetate; parenteral

76.2

307.7

310

XCK00

NOMESCO Finland

Perimetry

16.4

307.7

1171

974

H53.4

ICD-10 Finland

Visual field defects

15.9

307.7

376

258

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.1

307.7

1495

4144

L04AA27

ATC

[U] fingolimod

91.4

307.7

175

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

11.9

307.7

516

491

109

Kela drug reimbursment

Multiple sclerosis

77.1

307.7

797

128

L04AX07

ATC

dimethyl fumarate; oral

52.0

307.7

231

H47.3

ICD-10 Finland

Other disorders of optic disc

1464.7

307.7

513

XCD10

NOMESCO Finland

Electrophysiological examination of eye

12.5

307.7

385

337

L03AB07

ATC

interferon beta-1a; parenteral

80.1

307.7

411

N86

ICPC

Multiple sclerosis

64.8

307.7

328

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

8.3

307.7

1113

1763

H46

ICD-10 Finland

Optic neuritis

11408.8

307.7

1497

G35

ICD-10 Finland

Multiple sclerosis

68.4

307.7

982

188

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.1

307.7

891

2114

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

4186.3

307.7

719

H47.2

ICD-10 Finland

Optic atrophy

+∞

307.7

659

164

Kela drug reimbursment

Fingolimod

83.8

307.7

237

H47.1

ICD-10 Finland

Papilloedema, unspecified

2534.8

307.7

861

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

33.2

307.7

214

L03AB08

ATC

interferon beta-1b; parenteral

94.5

307.7

172

TAB00

NOMESCO Finland

Lumbar puncture

10.3

307.7

735

848

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

81.8

307.7

717

106

353

Kela drug reimbursment

Cladribine and fingolimod

85.9

307.7

212

CS494

NOMESCO Finland

Other visual field testing

10.7

301.1

338

340

XCK10

NOMESCO Finland

Photography of fundus of eye

4.9

298.4

747

1768

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

10.1

253.2

296

314

N04BB01

ATC

amantadine; oral

12.9

250.0

246

202

N07XX09

ATC

[U] dimethyl fumarate

54.4

249.9

142

H53.1

ICD-10 Finland

Subjective visual disturbances

4.9

237.2

581

1339

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

19.0

235.5

187

103

S01EC01

ATC

acetazolamide; systemic

9.9

228.0

270

291

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.1

220.4

694

1938

2AB04, ,

NOMESCO Finland

44.3

188.6

112

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

8.3

183.6

249

318

M03BX01

ATC

baclofen; systemic

8.4

173.6

232

291

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

17.0

171.3

143

XA800

NOMESCO Finland

Neuropsychological investigation

5.0

161.7

367

786

Z3229

NOMESCO Finland

Other healthcare associate professional

3.6

149.4

545

1663

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.7

137.5

163

175

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

46.1

130.8

36703

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris

+∞

121.5

116

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

21.1

120.9

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

+∞

120.4

115

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

13.6

117.9

111

N06BA07

ATC

modafinil; oral

19.8

117.5

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

6.4

116.8

198

322

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

7.7

112.6

160

215

L04AK02

ATC

teriflunomide; oral

41.3

107.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

107.0

504

1785

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

35.8

106.9

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.9

101.9

128

148

H53.9

ICD-10 Finland

Visual disturbance, unspecified

4.5

101.6

258

602

4AA23, ,

NOMESCO Finland

53.5

101.5

AA1AD

NOMESCO Finland

CT of head and brain

2.2

101.3

1160

6258

Z3231

NOMESCO Finland

Registered nurse

2.1

98.0

1279

7242

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

17.5

90.4

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

124.2

90.3

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

10.0

89.2

102

104

XKD06

NOMESCO Finland

Physiologic investigation of micturition

5.0

89.0

198

414

ZX120

NOMESCO Finland

Intravenous

2.7

83.1

489

1943

E23.00

ICD-10 Finland

Panhypopituitarism

15.4

81.1

H57.1

ICD-10 Finland

Ocular pain

3.7

78.0

258

729

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

10.1

75.6

R51.80

ICD-10 Finland

Headache

2.2

75.4

817

4250

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

9.0

75.3

105

3773B

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]

+∞

74.2

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.1

72.8

110

158

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

6.2

68.8

119

197

G04BD09

ATC

trospium; oral

5.1

68.6

148

301

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.3

67.7

138

267

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

230.4

66.4

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

117.0

64.0

PAW37

NOMESCO Finland

Biopsy of temporal artery

11.8

63.6

L04AG12

ATC

ofatumumab; parenteral

220.1

63.3

H53.2

ICD-10 Finland

Diplopia

3.9

63.1

195

525

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

6.5

63.0

103

161

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

627.8

63.0

XKD00

NOMESCO Finland

Uroflowmetry

2.2

61.5

569

2762

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

60.5

1730

12179

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

8.1

60.1

102

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

9.9

59.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

58.8

356

1426

ZXA10

NOMESCO Finland

Bilateral

2.0

58.3

776

4313

H54.7

ICD-10 Finland

Unspecified visual loss

8.9

57.9

H54.4

ICD-10 Finland

Blindness, monocular

17.6

57.6

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

55.9

363

1503

L03AB13

ATC

peginterferon beta-1a; parenteral

78.8

55.1

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.4

54.4

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

8.5

54.0

L04AE01

ATC

fingolimod; oral

99.8

53.9

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

53.7

280

1038

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

53.3

308

1204

Z2445

NOMESCO Finland

Psychologist

3.0

53.2

246

853

H02AB04

ATC

methylprednisolone; systemic

2.0

53.0

622

3297

R1250

NOMESCO Finland

Evaluation of functional capability

4.2

52.9

143

349

H02AB09

ATC

hydrocortisone; systemic

3.8

52.9

165

447

N03AX12

ATC

[U] gabapentin; oral

2.0

51.9

693

3842

101

Kela drug reimbursment

Anterior pituitary hypofunction

7.1

51.2

110

N03AX14

ATC

levetiracetam; systemic

3.8

51.2

162

443

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

51.1

260

951

H34.1

ICD-10 Finland

Central retinal artery occlusion

12.0

50.6

L04AA40

ATC

cladribine; oral

109.4

49.9

XKC03

NOMESCO Finland

Water cystometry

3.7

49.5

160

444

L04AX01

ATC

azathioprine; systemic

3.0

49.3

229

796

N03AX16

ATC

[U] pregabalin

1.8

49.1

931

5761

H02AB06

ATC

prednisolone; systemic

1.6

48.7

1863

13897

G04BD12

ATC

mirabegron; oral

2.2

48.5

447

2156

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

6.0

48.2

147

36702

ICD-8 Finland

Inflammation of optic nerve and retina, Neuritis optica. Papillitis

+∞

48.0

R4150

NOMESCO Finland

Neuropsychological rehabilitation

7.3

47.9

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.4

47.8

176

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.1

47.0

482

2423

N03AE01

ATC

clonazepam; systemic

2.7

46.8

272

1065

UKC02

NOMESCO Finland

Cystoscopy

2.0

46.3

573

3085

L04AA52

ATC

[U] ofatumumab; parenteral

161.9

45.9

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

10.8

45.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

45.1

860

5314

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

44.9

268

1063

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

44.6

507

2646

A02BC02

ATC

pantoprazole; systemic

1.6

44.6

2611

21380

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

10.1

44.2

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

5.8

44.2

142

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

15.3

43.4

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

7.1

42.8

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

9.2

42.2

N03AF02

ATC

oxcarbazepine; oral

3.1

42.0

180

597

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.4

41.8

G91.1

ICD-10 Finland

Obstructive hydrocephalus

10.3

41.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

41.3

1574

11590

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.9

41.3

127

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

41.2

486

2567

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.9

40.8

123

325

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

9.7

40.4

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.7

40.2

127

347

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

13.2

40.0

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.8

39.8

128

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

39.7

135

388

37799

ICD-8 Finland

Other diseases of retina and optic nerve, Unspecified

+∞

39.6

3773A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]

+∞

39.6

Z3226

NOMESCO Finland

Physiotherapist

1.8

39.6

738

4511

Z2446

NOMESCO Finland

Social worker

2.3

39.6

320

1458

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

12.4

38.4

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

9.9

38.3

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

14.1

38.2

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.0

36.6

163

553

R4110

NOMESCO Finland

Physiotherapy

1.6

36.2

1049

7192

TKC22

NOMESCO Finland

Catheterisation instruction

3.9

36.1

106

275

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

36.0

222

894

34099

ICD-8 Finland

Multiple sclerosis

68.9

36.0

102

Kela drug reimbursment

Diabetes insipidus

13.2

35.7

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.6

35.6

124

XCH00

NOMESCO Finland

Eye pressure measurement

2.7

35.2

193

733

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

12.2

35.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

34.9

439

2364

F05

ICPC

Visual disturbance other

3.1

34.3

149

498

R42

ICD-10 Finland

Dizziness and giddiness

1.7

34.2

831

5441

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

9.6

34.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

34.0

540

3136

N05CF01

ATC

zopiclone; oral

1.6

33.6

1163

8287

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

33.0

1132

8044

XCD20

NOMESCO Finland

Photoangiography of eye

4.4

32.5

186

R33

ICD-10 Finland

Retention of urine

2.2

32.1

273

1269

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

31.9

442

2455

SPAT1229

SPAT

Assessment of need for aid

2.2

31.9

286

1357

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

31.7

550

3277

37790

ICD-8 Finland

Other diseases of retina and optic nerve, Atrophia (et degeneratio) nervi optici (tabica excepta)

+∞

31.3

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

31.2

252

1146

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

31.2

565

3407

R35

ICD-10 Finland

Polyuria

2.3

31.1

258

1187

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

31.0

588

3593

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

3.7

30.9

100

278

N28

ICPC

Limited function/disability (N)

4.0

30.7

216

CS2P4

NOMESCO Finland

Optic nerve head imaging

5.9

30.5

N05BA09

ATC

clobazam; oral

6.0

30.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

30.1

590

3636

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

11.6

30.0

G04BD08

ATC

solifenacin; oral

2.3

30.0

238

1074

N03AF01

ATC

carbamazepine; oral, rectal

2.4

29.7

201

845

R4120

NOMESCO Finland

Occupational therapy

2.1

29.7

280

1355

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

29.4

563

3445

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

8.7

29.3

H53.8

ICD-10 Finland

Other visual disturbances

4.1

29.1

198

Z2221

NOMESCO Finland

Medical doctor

1.5

28.9

1077

7751

J01EA01

ATC

trimethoprim; systemic

1.5

28.8

998

7072

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.7

28.7

259

N02AX02

ATC

tramadol; systemic, rectal

1.5

28.7

1522

11770

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

28.5

213

936

H54.1

ICD-10 Finland

Severe visual impairment, binocular

48.9

28.4

L28

ICPC

Limited function/disability (L)

1.7

28.2

596

3743

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.7

28.2

140

H47.4

ICD-10 Finland

Disorders of optic chiasm

+∞

28.2

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

4.2

27.8

179

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

10.8

27.8

C10AC01

ATC

colestyramine; oral

3.0

27.6

124

423

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.1

27.6

267

1305

N02BE01

ATC

paracetamol; systemic, rectal

1.6

27.5

3453

31442

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

27.3

963

6836

G04BD07

ATC

tolterodine; oral

2.5

27.3

179

742

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

26.9

1299

9832

A28

ICPC

Limited function/disability NOS

1.7

26.9

532

3280

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

32.1

26.8

N03AX11

ATC

topiramate; oral

2.8

26.4

134

489

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.5

26.4

269

H02AB07

ATC

prednisone; oral

1.7

26.4

499

3038

N99

ICPC

Neurological disease other

4.3

26.0

158

N06AX16

ATC

venlafaxine; oral

1.7

25.7

582

3716

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.6

25.7

240

A02BC01

ATC

omeprazole; systemic

1.5

25.6

967

6953

H26.4

ICD-10 Finland

After-cataract

2.0

25.4

305

1613

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.6

25.4

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.3

25.3

157

ZXC95

NOMESCO Finland

Use of surgical navigator

4.3

25.3

153

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

25.3

878

6198

R50.9

ICD-10 Finland

Fever, unspecified

1.7

25.2

582

3735

H52.1

ICD-10 Finland

Myopia

2.4

25.1

176

752

ZXD05

NOMESCO Finland

Urgent procedure

1.5

25.0

1161

8696

G44.2

ICD-10 Finland

Tension-type headache

1.7

24.8

559

3564

H30.2

ICD-10 Finland

Posterior cyclitis

8.1

24.7

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.0

24.7

109

368

H50.1

ICD-10 Finland

Divergent concomitant strabismus

5.4

24.5

C03CA01

ATC

furosemide; systemic

1.5

24.4

871

6181

WX882

NOMESCO Finland

High dependency care

2.7

24.3

131

494

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.1

24.1

163

N29

ICPC

Neurological sympt/complt other

3.3

24.0

286

37791

ICD-8 Finland

Other diseases of retina and optic nerve, Papilloedema. Stasis papillae

+∞

24.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

23.9

565

3645

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.0

23.7

104

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.4

23.6

136

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

23.5

202

942

N03AX09

ATC

lamotrigine; oral

2.1

23.4

224

1091

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

23.3

320

1767

H54.5

ICD-10 Finland

Severe visual impairment, monocular

6.8

23.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

23.1

332

1860

H40.0

ICD-10 Finland

Glaucoma suspect

2.0

23.1

269

1406

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.1

23.0

304

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

5.7

22.9

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.9

22.5

107

377

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.1

22.3

294

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

22.3

449

2776

P85

ICPC

Mental retardation

8.3

22.2

H54.0

ICD-10 Finland

Blindness, binocular

27.5

22.2

114

Kela drug reimbursment

Glaucoma

2.0

22.1

263

1385

H48.1

ICD-10 Finland

Retrobulbar neuritis in diseases classified elsewhere

+∞

21.9

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

8.5

21.9

A02BC03

ATC

lansoprazole; oral

1.5

21.7

964

7125

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

8.8

21.5

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.3

21.4

167

749

N03AG01

ATC

valproic acid; systemic, rectal

2.0

21.2

238

1228

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

21.0

174

799

WX892

NOMESCO Finland

Monitored bed care

1.9

20.9

269

1454

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

8.0

20.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

20.9

157

693

H47.6

ICD-10 Finland

Disorders of visual cortex

+∞

20.8

H47

ICD-10 Finland

Other disorders of optic [2nd] nerve and visual pathways

+∞

20.8

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.6

20.8

S01ED51

ATC

timolol, combinations; ophthalmic

2.0

20.6

232

1198

N03AX18

ATC

lacosamide; systemic

4.8

20.5

G03.9

ICD-10 Finland

Meningitis, unspecified

8.2

20.5

N06AX21

ATC

duloxetine; oral

1.7

20.3

444

2803

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

20.3

269

R5110, ,

SPAT

2.0

20.0

221

1135

M03BX02

ATC

tizanidine; oral

1.4

19.8

2318

20060

G04CA02

ATC

tamsulosin; oral

1.5

19.7

612

4195

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

19.7

135

572

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.8

19.5

157

N02BF01

ATC

gabapentin; oral

1.8

19.5

300

1716

H34.2

ICD-10 Finland

Other retinal artery occlusions

5.7

19.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

19.4

971

7315

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.2

19.4

240

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

19.4

718

5107

D35.30

ICD-10 Finland

Craniopharyngoma

46.2

19.2

J01FF01

ATC

clindamycin; systemic

1.4

19.0

946

7116

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

19.0

204

1037

ZXE00

NOMESCO Finland

One hour or less

1.4

19.0

1435

11583

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

18.9

296

1703

3771A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic atrophy

+∞

18.8

L04AA06

ATC

mycophenolic acid; systemic

3.0

18.6

278

A06AD11

ATC

lactulose; oral

1.6

18.5

449

2904

H53.0

ICD-10 Finland

Amblyopia ex anopsia

3.8

18.5

145

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.5

2766

24729

H01AC01

ATC

somatropin; parenteral

5.2

18.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

18.4

961

7288

J01MA02

ATC

ciprofloxacin; systemic

1.4

18.3

1306

10432

N06AB04

ATC

citalopram; systemic

1.5

18.1

742

5378

M31.6

ICD-10 Finland

Other giant cell arteritis

14.4

18.1

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.7

18.0

152

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.8

17.8

323

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

7.3

17.8

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.3

17.8

105

183

Kela drug reimbursment

Lamotrigin and topiramate

3.9

17.8

131

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

17.6

228

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

6.3

17.5

N06AA09

ATC

amitriptyline; systemic

1.7

17.5

319

1917

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

17.4

1329

10704

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

17.4

1013

7812

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

17.4

146

675

6BA02, ,

NOMESCO Finland

7.1

17.4

N30.0

ICD-10 Finland

Acute cystitis

1.5

17.3

593

4141

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

4.3

17.3

103

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

17.3

441

2886

J01AA02

ATC

doxycycline; systemic

1.4

17.3

2836

25557

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

17.1

793

5873

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.5

17.1

172

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

17.0

1532

12642

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.4

16.9

116

493

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

16.8

1371

11140

N05BA01

ATC

diazepam; systemic, rectal

1.6

16.8

436

2865

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

16.6

370

U13

ICPC

Bladder symptom/complaint other

2.4

16.6

113

478

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.4

16.5

176

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.8

16.3

130

A02BA02

ATC

ranitidine; systemic

1.5

16.3

601

4257

R60.0

ICD-10 Finland

Localized oedema

1.6

16.3

385

2472

RS222, ,

NOMESCO Finland

3.5

16.3

163

SPAT1301

SPAT

No procedures

1.4

16.3

1073

8431

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

16.1

314

1920

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.1

16.0

R4190

NOMESCO Finland

Nutritional therapy

2.1

15.9

157

774

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

15.9

204

1103

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

15.8

1393

11423

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

15.8

496

3400

PA2AD

NOMESCO Finland

CT angiography of brain

4.0

15.7

111

SPAT1216

SPAT

Assessment of functional ability

1.5

15.7

470

3186

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

15.7

152

744

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

15.7

722

5333

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

15.7

765

5711

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

15.7

246

1416

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

15.6

158

786

H52.0

ICD-10 Finland

Hypermetropia

2.6

15.6

352

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

15.5

291

1760

N03AB02

ATC

phenytoin; systemic

3.8

15.5

121

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

15.5

368

2365

XCW12

NOMESCO Finland

Assessment of colour vision

22.1

15.5

L04AX09

ATC

diroximel fumarate; oral

160.6

15.5

ZXA00

NOMESCO Finland

Right side

1.4

15.4

827

6276

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

5.2

15.3

J01CA08

ATC

pivmecillinam; oral

1.3

15.2

1521

12686

RK110, ,

NOMESCO Finland

4.3

15.0

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.4

15.0

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

6.8

14.8

S01EE01

ATC

latanoprost; ophthalmic

1.9

14.8

179

948

ZXC86

NOMESCO Finland

Use of endoscopic device

5.2

14.8

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

31.8

14.8

H40.11

ICD-10 Finland

Low pressure glaucoma

2.8

14.8

264

J01DB01

ATC

cefalexin; oral

1.4

14.7

3165

29252

RS221, ,

NOMESCO Finland

2.9

14.6

227

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

H47.5

ICD-10 Finland

Disorders of other visual pathways

+∞

14.6

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

5.0

14.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

14.5

307

1918

J01DA01

ATC

[U] cefalexin

1.3

14.5

2253

19886

ZXY02

NOMESCO Finland

Neuropsychologist

4.6

14.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

14.4

164

851

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

6.0

14.3

S01ED01

ATC

timolol; ophthalmic

2.3

14.3

105

460

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

17.0

14.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

14.3

344

2219

R39.1

ICD-10 Finland

Other difficulties with micturition

2.4

14.2

405

N05BA04

ATC

oxazepam; oral

1.4

14.1

898

6994

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.7

14.0

116

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

14.0

309

1951

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

13.9

122

575

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.6

13.9

126

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

13.9

828

6377

WX002

NOMESCO Finland

Sedation and analgesia

1.4

13.9

613

4486

SPAT1262

SPAT

Handing over of treatment supplies

1.5

13.8

535

3820

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

5.6

13.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

13.8

327

2101

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

13.7

1092

8787

W19

ICD-10 Finland

Unspecified fall

1.6

13.7

323

2073

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

13.6

616

4529

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.5

13.6

335

36709

ICD-8 Finland

Inflammation of optic nerve and retina, Unspecified

+∞

13.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

13.5

996

7925

R06.0

ICD-10 Finland

Dyspnoea

1.4

13.5

866

6747

G04BD11

ATC

fesoterodine; oral

2.4

13.5

360

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.1

13.4

E66.8

ICD-10 Finland

Other obesity

1.8

13.4

209

1202

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

18.3

13.3

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

13.3

2023

17717

SPAT1153

SPAT

Removal of sutures

1.3

13.3

1000

7978

N06AX11

ATC

mirtazapine; oral

1.3

13.3

1165

9499

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.1

13.3

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

13.8

13.2

WX872

NOMESCO Finland

Intensive care

2.0

13.2

151

787

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

13.1

270

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.1

1287

10653

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

13.0

324

2105

J01MA12

ATC

levofloxacin; systemic

1.4

13.0

565

4122

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

10.1

12.9

S01EA05

ATC

brimonidine; ophthalmic

2.6

12.9

301

RD210, ,

NOMESCO Finland

2.5

12.9

325

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.4

12.9

U07

ICPC

Urine symptom/complaint other

1.7

12.8

242

1468

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

12.7

324

2117

H53

ICD-10 Finland

Visual disturbances

3.6

12.7

115

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

12.7

615

4572

R51

ICD-10 Finland

Headache

1.7

12.7

215

1266

ZXA05

NOMESCO Finland

Left side

1.4

12.7

750

5763

S18

ICPC

Laceration/cut

1.3

12.5

1495

12672

M05BA04

ATC

alendronic acid; oral

1.7

12.5

235

1425

R11

ICD-10 Finland

Nausea and vomiting

1.6

12.4

309

2007

H50.31

ICD-10 Finland

Intermittent exotropia

3.4

12.4

131

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.0

12.4

U02

ICPC

Urinary frequency/urgency

1.5

12.4

477

3398

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

12.4

1042

8431

G40.10

ICD-10 Finland

Simple partial seizures

4.0

12.4

H25.8

ICD-10 Finland

Other senile cataract

1.6

12.3

277

1758

R3120

NOMESCO Finland

Training in mobility skills

5.4

12.3

R51.81

ICD-10 Finland

Facial pain NOS

2.3

12.3

414

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.8

12.3

211

H50.0

ICD-10 Finland

Convergent concomitant strabismus

3.6

12.2

113

RF120, ,

NOMESCO Finland

3.1

12.2

163

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.1

1535

13091

G91.8

ICD-10 Finland

Other hydrocephalus

15.9

12.1

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.4

12.0

124

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.6

12.0

276

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

18.1

12.0

A10AB05

ATC

insulin aspart; parenteral

1.7

12.0

246

1525

U05

ICPC

Urination problems other

1.9

12.0

155

842

Z50.1

ICD-10 Finland

Other physical therapy

1.8

11.9

170

951

E23.05

ICD-10 Finland

Lack of TSH

5.7

11.9

R13

ICD-10 Finland

Dysphagia

1.7

11.9

220

1326

4AA36, ,

NOMESCO Finland

46.8

11.9

S01EC04

ATC

brinzolamide; ophthalmic

2.1

11.8

113

552

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

11.7

205

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

11.7

334

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

11.6

181

1040

F83

ICD-10 Finland

Mixed specific developmental disorders

3.8

11.6

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.6

788

6175

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.6

381

2631

N18

ICPC

Paralysis/weakness

2.6

11.6

258

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

11.6

202

1200

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.5

11.5

108

A04

ICPC

Weakness/tiredness general

1.4

11.5

513

3755

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

11.5

202

SPAT1254

SPAT

Administration of medicine

1.4

11.5

480

3473

AAF10

NOMESCO Finland

Lumboperitoneal shunt

120.4

11.4

R62.0

ICD-10 Finland

Delayed milestone

3.7

11.4

3AX01, ,

NOMESCO Finland

5.4

11.3

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.6

11.3

100

L01BB04

ATC

cladribine; systemic

35.1

11.3

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

11.3

311

2070

V03AE02

ATC

sevelamer; oral

4.9

11.2

G93.0

ICD-10 Finland

Cerebral cysts

4.6

11.2

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.9

11.2

130

682

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

11.2

194

1151

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.8

11.2

194

C07AB07

ATC

bisoprolol; oral

1.3

11.1

1454

12416

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

11.1

148

812

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

11.1

324

2183

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

11.0

229

1424

WW400

NOMESCO Finland

Plasmaferesis

11.2

11.0

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

11.0

367

2541

R52.9

ICD-10 Finland

Pain, unspecified

1.5

11.0

316

2121

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

11.0

904

7275

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

10.9

148

RK320, ,

NOMESCO Finland

3.9

10.8

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

10.8

2740

25201

R02

ICPC

Shortness of breath/dyspnoea

1.5

10.8

409

2904

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

10.8

106

524

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

10.8

788

6237

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

10.7

298

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

10.7

319

2157

AA1AA

NOMESCO Finland

Head X-ray examination

3.5

10.7

104

H15.0

ICD-10 Finland

Scleritis

5.6

10.7

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

10.7

387

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.4

10.7

114

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

10.6

654

5047

R53

ICD-10 Finland

Malaise and fatigue

1.3

10.6

828

6615

L17

ICPC

Foot/toe symptom/complaint

1.3

10.5

944

7678

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.2

10.5

S01EE05

ATC

tafluprost; ophthalmic

2.1

10.5

101

495

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

10.5

456

3320

301

Kela drug reimbursment

Growth hormone

9.2

10.5

S97

ICPC

Chronic ulcer skin

1.8

10.5

169

982

D32.03

ICD-10 Finland

Benign meningioma in ventricles

14.2

10.5

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.8

10.5

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

10.4

239

1523

3774A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Other disorders of optic nerve

+∞

10.4

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

10.4

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

10.4

378

A46

ICD-10 Finland

Erysipelas

1.4

10.4

406

2899

G47.3

ICD-10 Finland

Sleep apnoea

1.3

10.4

676

5257

R01AD09

ATC

mometasone; nasal

1.2

10.3

1651

14389

XA412

NOMESCO Finland

VEP

16.1

10.3

A02BC05

ATC

esomeprazole; systemic

1.3

10.3

1341

11418

127

Kela drug reimbursment

Transplant complication

2.6

10.3

220

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

4.9

10.2

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.5

10.2

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

10.2

800

6387

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

10.2

135

739

R4130

NOMESCO Finland

Speech therapy

2.1

10.2

427

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

10.2

204

1258

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

3.5

10.2

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.7

10.1

J01CA04

ATC

amoxicillin; systemic

1.3

10.1

3161

29667

SPAT1263

SPAT

Sampling

1.3

10.1

1462

12592

XCW10

NOMESCO Finland

Assessment of vision

3.0

10.1

144

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

10.1

616

4744

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.0

10.1

139

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.9

10.1

155

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

10.0

133

729

F99

ICPC

Eye/adnexa disease other

4.0

10.0

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

10.0

316

2164

TK800

NOMESCO Finland

Hemodialysis

2.4

10.0

277

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.5

10.0

G51.0

ICD-10 Finland

Bell palsy

2.1

10.0

424

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

10.0

189

1148

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

10.0

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.0

C08CA01

ATC

amlodipine; oral

1.3

10.0

1071

8907

K02.1

ICD-10 Finland

Caries of dentine

1.2

9.9

2205

19884

B01AB05

ATC

enoxaparin; parenteral

1.3

9.9

963

7906

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.1

9.9

135

U04

ICPC

Incontinence urine

1.8

9.9

153

879

H52.2

ICD-10 Finland

Astigmatism

2.3

9.9

335

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

7.6

9.9

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

16.7

9.9

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

9.9

176

1053

RS122, ,

NOMESCO Finland

5.1

9.8

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

9.8

355

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

9.8

183

1108

ABD40

NOMESCO Finland

Implantation of spinal injection device

26.1

9.8

RT150, ,

NOMESCO Finland

4.9

9.8

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

9.8

299

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

9.7

325

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

3.7

9.7

S06.0

ICD-10 Finland

Concussion

1.5

9.7

358

2530

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

9.7

364

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.1

9.6

132

SFA20

NOMESCO Finland

Two-surface restoration

1.2

9.6

2144

19312

N02AA05

ATC

oxycodone; systemic

1.4

9.6

479

3569

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

9.6

443

3258

N01

ICPC

Headache

1.4

9.6

429

3138

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.6

1414

12186

S01EE04

ATC

travoprost; ophthalmic

2.5

9.6

228

SPAT1260

SPAT

Consultation of another employee

1.4

9.5

561

4292

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

9.5

399

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.0

9.5

133

UDM02

NOMESCO Finland

Sinoscopy

2.2

9.5

347

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.5

1155

9737

SFA10

NOMESCO Finland

One-surface restoration

1.2

9.4

2006

17965

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

9.4

103

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

9.4

1910

17021

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

100.3

9.4

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

100.3

9.4

WX402

NOMESCO Finland

General anaesthesia

1.3

9.4

708

5616

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

30.1

9.4

3770A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Papilloedema

+∞

9.4

S29

ICPC

Skin symptom/complaint other

1.3

9.4

609

4731

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

5.2

9.4

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

12.4

9.3

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.4

9.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

9.3

261

1744

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

9.3

450

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

9.3

168

1010

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.1

390

2830

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

9.1

234

1533

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

9.1

164

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

9.1

231

1510

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

11.5

9.1

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

8.3

9.0

L04AD02

ATC

tacrolimus; systemic

2.9

9.0

148

N02BF02

ATC

pregabalin; oral

1.6

9.0

185

1148

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

3.4

9.0

CEW99

NOMESCO Finland

Other operation on extraocular muscle

15.6

9.0

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

15.6

9.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

9.0

294

2027

F94

ICPC

Blindness

36.8

9.0

A10AC01

ATC

insulin (human); parenteral

1.6

9.0

232

1522

M79.6

ICD-10 Finland

Pain in limb

1.2

9.0

1430

12406

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

8.9

254

1702

H26.2

ICD-10 Finland

Complicated cataract

2.7

8.9

166

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.9

1438

12491

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

8.9

115

626

AA2DG

NOMESCO Finland

Very extensive magnetic examination of the head and orbit

24.1

8.9

L02

ICPC

Back symptom/complaint

1.4

8.9

340

2420

A01

ICPC

Pain general/multiple sites

1.5

8.8

287

1978

WX290

NOMESCO Finland

Other blockage of nerve

1.2

8.7

1742

15455

G44.8

ICD-10 Finland

Other specified headache syndromes

2.3

8.7

270

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

14.0

8.7

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

50.1

8.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

8.7

365

2642

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

8.7

199

1271

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

8.7

200

1279

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

6.6

8.6

R06AE07

ATC

cetirizine; oral

1.2

8.6

1580

13892

J02AC01

ATC

fluconazole; systemic

1.2

8.6

1415

12301

Z71.8

ICD-10 Finland

Other specified counselling

1.2

8.6

1089

9203

G50.1

ICD-10 Finland

Atypical facial pain

2.3

8.6

284

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

8.6

167

1023

H35.8

ICD-10 Finland

Other specified retinal disorders

4.0

8.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.6

1686

14929

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

8.6

356

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

8.5

142

834

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

10.0

8.5

H50.30

ICD-10 Finland

Intermittent esotropy

3.8

8.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.5

201

1293

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

8.5

125

709

UJF32

NOMESCO Finland

Coloscopy

1.3

8.5

764

6199

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

20.1

8.5

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

8.4

365

34109

ICD-8 Finland

Other demyelinating diseases of central nervous system, Unspecified

90.2

8.4

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

8.4

344

2478

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

8.4

606

4775

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

8.4

840

6906

H01

ICPC

Ear pain/earache

1.4

8.4

404

2993

SPAT1325

SPAT

Vaccination

1.2

8.4

1054

8899

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.1

8.4

106

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

7.9

8.3

E23.2

ICD-10 Finland

Diabetes insipidus

6.7

8.3

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

8.3

222

1467

3773X

ICD-9 Finland

Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS OPTICA ALIA SEU NUD]

+∞

8.3

3772A

ICD-9 Finland

Disorders of optic nerve and visual pathways, Other disorders of optic disk

+∞

8.3

N04BC05

ATC

pramipexole; oral

1.6

8.3

215

1412

137

Kela drug reimbursment

Uraemia requiring dialysis

3.1

8.3

112

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

8.2

883

7316

F01

ICPC

Eye pain

1.9

8.2

527

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

8.2

1308

11320

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.4

8.2

215

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.8

8.2

145

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

8.2

329

J01FA06

ATC

roxithromycin; oral

1.2

8.2

1324

11476

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

14.5

8.2

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

8.2

424

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

8.1

213

1404

2132

FHL

Ventricular operators sunt

33.4

8.1

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

33.4

8.1

G53.2*D86.8

ICD-10 Finland

Multiple cranial nerve palsies in sarcoidosis

33.4

8.1

H43.9

ICD-10 Finland

Disorder of vitreous body, unspecified

3.2

8.1

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

17.2

8.1

G40.89

ICD-10 Finland

Other epilepsy

4.0

8.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.0

419

3144

E23.06

ICD-10 Finland

Empty sella

8.9

8.0

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.3

8.0

236

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

10.0

8.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.0

430

3242

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.8

8.0

136

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

4.1

8.0

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.5

8.0

188

G44.0

ICD-10 Finland

Cluster headache syndrome

2.5

8.0

188

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

7.9

185

1187

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

7.9

202

1323

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

7.9

336

2436

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

7.9

154

945

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

7.9

175

1109

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.9

1366

11914

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

7.9

395

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

4.4

7.9

XX4AW, ,

NOMESCO Finland

4.4

7.9

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.9

7.9

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.9

7.9

S01EE03

ATC

bimatoprost; ophthalmic

2.2

7.9

302

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

7.9

113

637

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

7.9

232

SPAT1255

SPAT

Intravenous administration of medicine

1.6

7.8

199

1302

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.8

119

682

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.8

7.8

123

712

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

7.8

651

5227

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

7.8

688

5564

ZXC40

NOMESCO Finland

Use of ultrasound

3.4

7.8

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.2

7.8

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

10.8

7.8

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

10.8

7.8

R01AD08

ATC

fluticasone; nasal

1.2

7.8

985

8313

N06AB03

ATC

fluoxetine; oral

1.4

7.7

396

2963

G37.8

ICD-10 Finland

Other specified demyelinating diseases of central nervous system

15.0

7.7

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.9

7.7

117

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

7.7

325

B05DA

ATC

Isotonic solutions

3.2

7.7

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

7.6

227

1538

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.7

7.6

J01MA06

ATC

norfloxacin; oral

1.4

7.6

393

2944

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.0

7.6

107

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.0

7.6

RL140, ,

NOMESCO Finland

6.7

7.6

J01FA10

ATC

azithromycin; systemic

1.2

7.6

2123

19362

A08

ICPC

Swelling

1.7

7.6

143

871

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

25.0

7.6

RF420, ,

NOMESCO Finland

2.5

7.6

193

H3603, E103,

ICD-10 Finland

2.8

7.5

135

H53.5

ICD-10 Finland

Colour vision deficiencies

10.0

7.5

Z43.5

ICD-10 Finland

Attention to cystostomy

3.8

7.5

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

7.5

137

827

A10AE04

ATC

insulin glargine; parenteral

1.5

7.5

269

1891

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

7.5

282

D33.30

ICD-10 Finland

Acoustic neuroma

3.7

7.5

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

7.4

137

829

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

7.4

249

1728

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

7.4

489

3801

Q85.1

ICD-10 Finland

Tuberous sclerosis

80.2

7.4

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.5

7.4

E0000UV, ,

ATC

1.2

7.4

1436

12649

WX140

NOMESCO Finland

Parabulbar anesthesy

1.7

7.4

122

717

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.8

7.4

533

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.3

169

1082

H02.4

ICD-10 Finland

Ptosis of eyelid

1.9

7.3

427

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

8.4

7.3

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

7.3

225

1536

L86

ICPC

Back syndrome with radiating pain

1.6

7.3

183

1195

M41.4

ICD-10 Finland

Neuromuscular scoliosis

10.9

7.3

H05.2

ICD-10 Finland

Exophthalmic conditions

6.8

7.3

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.8

7.3

RT274, ,

NOMESCO Finland

9.4

7.3

K59.0

ICD-10 Finland

Constipation

1.6

7.2

160

1014

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

7.2

185

1213

G04BD01

ATC

emepronium; systemic

3.4

7.2

N05CD07

ATC

temazepam; oral

1.4

7.2

294

2116

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

15.8

7.2

ZY010

NOMESCO Finland

Hospital outpatient

1.6

7.2

184

1206

S10

ICPC

Boil/carbuncle

1.6

7.2

179

1166

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

4.3

7.2

CEC00

NOMESCO Finland

Recession of extraocular muscle

4.3

7.2

J01DA09

ATC

[U] cefadroxil

1.2

7.2

865

7249

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.3

7.2

210

B01AC04

ATC

clopidogrel; oral

1.4

7.2

396

2998

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

7.2

230

1583

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.9

7.2

S04.0

ICD-10 Finland

Injury of optic nerve and pathways

30.1

7.1

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

30.1

7.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

7.1

838

7004

602

Kela drug reimbursment

Children's severe malnutrition

3.6

7.1

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

6.6

7.1

M05BX04

ATC

denosumab; parenteral

1.6

7.1

149

933

SPAT1211

SPAT

Application of soft bandage

1.4

7.1

265

1878

WX704

NOMESCO Finland

Intubation

1.5

7.1

240

1670

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.1

7.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

7.0

148

927

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

7.0

593

4765

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

7.0

549

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

7.0

390

2957

G04CA01

ATC

alfuzosin; oral

1.4

7.0

280

2010

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

7.0

189

1256

N88

ICPC

Epilepsy

3.3

7.0

H81.4

ICD-10 Finland

Vertigo of central origin

3.3

7.0

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

6.9

407

N05AH04

ATC

quetiapine; oral

1.3

6.9

582

4672

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.9

385

2917

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.9

340

2527

C08CA13

ATC

lercanidipine; oral

1.4

6.9

367

2762

H53.3

ICD-10 Finland

Other disorders of binocular vision

3.7

6.9

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

5.8

6.9

E22.80

ICD-10 Finland

Central precocious puberty

13.8

6.9

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

6.8

141

879

J45

ICD-10 Finland

Asthma

1.4

6.8

326

2411

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.4

6.8

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

4.1

6.8

N06AB10

ATC

escitalopram; oral

1.3

6.8

718

5927

181

Kela drug reimbursment

Retigabine and vigabatrin

10.9

6.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

6.8

121

727

G80.8

ICD-10 Finland

Other cerebral palsy

40.1

6.8

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

4.3

6.7

RS140, ,

NOMESCO Finland

4.3

6.7

-50

ICPC

Medication/prescr/renewal

1.7

6.7

117

699

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.7

296

2162

U08

ICPC

Urinary retention

2.2

6.7

230

G45.3

ICD-10 Finland

Amaurosis fugax

2.2

6.7

243

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

22.5

6.7

I50.0

ICD-10 Finland

Congestive heart failure

1.6

6.6

160

1036

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

3.0

6.6

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.0

6.6

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.6

529

SPAT1360

SPAT

Extensive global examination

1.5

6.6

196

1327

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.0

6.6

344

M01AX17

ATC

nimesulide; oral

1.3

6.6

663

5437

N07AA03

ATC

distigmine; systemic

6.4

6.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

6.6

689

5679

M54.5

ICD-10 Finland

Low back pain

1.2

6.6

1211

10585

A97

ICPC

No disease

1.3

6.6

562

4522

Z01.2

ICD-10 Finland

Dental examination

1.2

6.5

1625

14591

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

6.5

229

1604

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.4

6.5

182

M05BA07

ATC

risedronic acid; oral

1.9

6.5

374

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

6.5

157

1017

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

6.5

292

A12AA04

ATC

calcium carbonate; oral

2.3

6.5

201

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

6.5

425

3300

R31

ICD-10 Finland

Unspecified haematuria

1.4

6.5

255

1825

R03AC12

ATC

salmeterol; inhalant

1.7

6.5

120

729

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

6.5

526

R2110

NOMESCO Finland

Giving the first information

1.5

6.5

219

1525

K08.3

ICD-10 Finland

Retained dental root

1.5

6.5

204

1401

J20

ICD-10 Finland

Acute bronchitis

1.4

6.5

309

2288

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

6.4

162

1060

E000001, ,

ATC

1.3

6.4

653

5364

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.2

6.4

234

TK810

NOMESCO Finland

Hemofiltration

3.5

6.4

G37.0

ICD-10 Finland

Diffuse sclerosis

70.0

6.4

J01XE01

ATC

nitrofurantoin; oral

2.1

6.4

267

N06AB06

ATC

sertraline; oral

1.3

6.4

374

2856

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.4

115

693

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

6.4

604

4919

N76

ICPC

Neoplasm nervous system unspecified

14.3

6.4

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

6.4

104

610

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.4

1879

17108

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

6.4

131

817

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.4

1716

15506

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

6.4

179

1200

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

6.4

254

1823

SPAT1234

SPAT

Support of social functional capacity

1.6

6.3

138

873

D07AC01

ATC

betamethasone; topical

1.2

6.3

1155

10081

R03CA02

ATC

ephedrine; oral

8.1

6.3

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

11.0

6.3

H52.5

ICD-10 Finland

Disorders of accommodation

5.5

6.3

JN4BD

NOMESCO Finland

Extensive body CT

1.4

6.3

269

1955

G81.1

ICD-10 Finland

Spastic hemiplegia

9.3

6.3

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.9

6.3

429

G04BD10

ATC

darifenacin; oral

3.5

6.3

AAF00

NOMESCO Finland

Ventriculostomy

3.3

6.3

G37.3

ICD-10 Finland

Acute transverse myelitis in demyelinating disease of central nervous system

18.0

6.3

PH4YT

NOMESCO Finland

Dilatation of vein of head or brain

+∞

6.2

A11CC03

ATC

alfacalcidol; systemic

1.9

6.2

352

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.2

207

1436

2133

FHL

Suntin revisio

26.7

6.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

6.2

518

J01MA14

ATC

moxifloxacin; systemic

1.4

6.2

251

1809

P03

ICPC

Feeling depressed

1.3

6.2

350

2663

H3603, E113,

ICD-10 Finland

2.9

6.1

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.3

6.1

200

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.2

6.1

A02BA04

ATC

nizatidine; systemic

1.5

6.1

193

1325

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

6.1

265

1930

A03

ICPC

Fever

1.3

6.1

599

4899

D12

ICPC

Constipation

1.7

6.1

573

K07

ICPC

Swollen ankles/oedema

1.7

6.1

114

695

SPAT1167

SPAT

Insertion of urinary catheter

1.9

6.1

398

B05DB

ATC

Hypertonic solutions

3.0

6.1

SPAT1104

SPAT

Monitoring of emergency patient

1.5

6.0

185

1263

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

6.0

124

774

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.0

2502

23388

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

10.0

6.0

A10AE05

ATC

insulin detemir; parenteral

1.5

6.0

153

1004

N05BA12

ATC

alprazolam; oral

1.4

6.0

296

2203

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

299

225

14.26

320.96

1.7

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

490

746

7.33

312.58

1.5

1.7

459.00

1455.02

e6/l

1.33

394

599

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

489

747

7.30

310.93

1.4

1.7

17.73

27.32

e6/l

0.46

380

567

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

173

100.31

307.65

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

569

849

7.62

307.65

1.3

1.5

478.11

492.20

mg/l

0.14

540

805

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

310

101.57

307.65

1.2

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

359

288

13.57

307.65

1.2

1.1

45.22

37.31

mg/l

0.86

287

243

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

352

276

13.86

307.65

1.1

1.0

244.84

240.09

mg/l

0.06

301

243

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

355

270

14.30

307.65

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

481

688

7.79

307.65

1.4

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

181

44.00

303.97

3.1

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

485

759

7.12

301.31

1.3

1.5

3.58

3.71

mmol/l

1.88

452

716

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

258

196

13.98

274.99

1.2

1.1

1.06

1.11

u/l

0.34

105

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

312

343

9.77

260.05

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

348

545

6.89

214.51

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

333

507

7.06

210.71

1.1

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

794

2525

3.66

208.30

3.3

2.7

9.72

10.48

g/l

6.60

722

2325

(3016018) Differential panel - Cerebral spinal fluid

261

361

7.65

179.74

1.4

1.8

—

(3023410) Appearance of Cerebral spinal fluid

240

362

6.98

152.55

1.5

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

682

2377

3.24

151.50

2.6

2.4

29.28

22.42

au/ml

0.57

207

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

641

2172

3.31

149.03

1.4

1.3

52.36

48.05

au/ml

—

116

(3011412) CD3 cells [#/volume] in Blood

218

332

6.88

137.19

3.4

2.3

1.35

1.30

e9/l

0.23

191

290

(40760892) CBC W Ordered Manual Differential panel - Blood

2395

15837

2.24

133.16

10.8

6.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

183

238

8.00

132.54

3.5

2.5

0.23

0.21

e9/l

0.59

157

198

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

182

244

7.76

128.41

3.6

2.4

476.78

591.08

e6/l

1.51

154

197

(3001604) Monocytes [#/volume] in Blood

2475

16820

2.19

125.27

10.2

5.9

0.58

0.57

e9/l

1.13

2225

14620

(3006315) Basophils [#/volume] in Blood

2477

16847

2.19

125.00

10.2

6.0

0.04

e9/l

0.14

2225

14629

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

383

1052

3.91

121.62

1.8

1.5

0.27

6.09

iu/ml

0.50

207

(3019198) Lymphocytes [#/volume] in Blood

2516

17377

2.16

119.88

10.2

6.0

1.81

1.97

e9/l

3.51

2291

15488

(3013115) Eosinophils [#/volume] in Blood

2515

17455

2.15

117.12

10.4

6.2

0.20

0.19

e9/l

0.75

2269

15417

(3013650) Neutrophils [#/volume] in Blood by Automated count

2711

19368

2.19

117.11

12.2

9.0

4.11

4.05

e9/l

0.59

2451

16914

(3022096) Basophils/100 leukocytes in Blood

2279

15282

2.11

115.66

10.4

6.2

0.69

0.67

0.73

2196

14306

(3019069) Monocytes/100 leukocytes in Blood

2337

15881

2.10

113.67

10.6

6.4

8.72

8.39

6.10

2256

14932

(3006504) Eosinophils/100 leukocytes in Blood

2322

15787

2.09

112.21

10.4

6.1

2.92

2.84

0.83

2242

14816

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

173

266

6.75

107.70

2.9

2.2

14.54

13.66

0.42

167

259

(3002030) Lymphocytes/100 leukocytes in Blood

2373

16417

2.06

107.45

10.4

6.2

26.65

28.82

18.56

2288

15486

(1175426) CD3 cells/100 lymphocytes in Blood

174

271

6.66

107.00

3.0

2.2

75.00

72.26

1.23

168

260

(3018010) Neutrophils/100 leukocytes in Blood

2343

16188

2.05

105.82

10.1

6.0

58.74

56.59

15.89

2258

15254

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

422

1372

3.31

103.30

2.2

1.9

38.96

39.09

u/l

0.05

395

1241

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

164

263

6.45

98.00

1.3

1.72

1.98

mmol/l

2.90

148

246

(3024561) Albumin [Mass/volume] in Serum or Plasma

1989

13336

1.96

93.59

5.6

4.8

36.17

35.93

g/l

1.05

1869

12445

(3013826) Glucose [Moles/volume] in Serum or Plasma

2550

18659

1.97

91.95

5.9

4.7

6.49

6.57

mmol/l

1.16

2411

17278

(3006245) CD3-CD19+ cells/100 cells in Blood

122

157

7.98

88.98

3.3

2.6

6.96

11.88

2.91

114

148

(3000060) B lymphocytes [#/volume] in Blood

109

122

9.15

88.94

3.0

2.5

249.81

294.00

e6/l

0.13

(3028026) IgM [Mass/volume] in Serum or Plasma

501

1978

2.75

86.31

2.9

1.8

1.06

1.40

g/l

5.90

474

1822

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

167

7.56

85.67

1.1

1656.82

1520.40

miu/ml

0.50

123

167

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1990

13716

1.88

82.49

2.7

2.3

81.80

75.79

nmol/l

13.66

1844

12515

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

148

266

5.74

78.69

3.1

2.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

872

4690

2.09

73.52

2.4

29.88

29.76

0.19

840

4542

(3030467) Casts [#/volume] in Urine by Automated count

1391

8789

1.88

73.51

4.6

3.1

0.25

0.38

e6/l

2.13

1124

6664

(3018095) Leukocytes [#/volume] in Urine

1701

11460

1.83

73.07

5.7

3.6

70.81

92.16

e6/l

0.66

1262

7951

(3010503) CD19 cells [#/volume] in Blood

118

183

6.61

72.76

3.5

2.2

0.33

0.26

e9/l

0.13

118

178

(3002582) Erythrocytes [#/volume] in Urine

1479

9585

1.85

71.73

5.0

3.2

83.65

95.17

e6/l

0.11

1196

7332

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

111

165

6.89

71.23

1.7

—

(36304419) Bacteria [Presence] in Urine

1363

8677

1.86

69.51

4.6

3.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2113

15360

1.78

68.89

8.9

6.7

1.21

mmol/l

0.58

1813

13163

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

105

153

7.02

68.62

3.2

2.4

26.49

28.05

0.50

147

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

107

160

6.84

68.28

1.3

67.08

68.50

0.04

(3000850) Epithelial cells [#/volume] in Urine

1115

6689

1.92

68.18

3.9

2.5

4.75

6.50

e6/l

6.42

1030

5983

(3037467) Urinalysis macro (dipstick) panel - Urine

2886

23087

1.85

67.18

6.5

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2776

22014

1.81

65.66

6.9

4.2

875.09

1612.44

e6/l

0.47

280

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

9.15

65.53

3.9

2.5

—

(3026782) Osmolality of Urine

1059

6331

1.91

64.95

4.0

2.8

544.05

545.21

mosm/kgh2o

0.06

951

5438

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3024

24668

1.87

64.58

8.8

7.2

78.46

77.55

u/l

0.40

2871

23308

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1931

13919

1.73

62.69

8.3

6.1

1.21

mmol/l

1.05

1792

12768

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1383

9065

1.79

62.66

2.4

2.1

188.30

220.59

u/l

0.46

1309

8543

(3026008) Bacteria identified in Urine by Culture

1454

9680

1.78

62.41

3.9

2.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

142

304

4.80

61.97

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2182

16330

1.72

61.29

6.5

6.0

10.67

11.61

umol/l

2.51

2075

15465

(3015736) pH of Urine

1848

13312

1.71

58.90

4.5

3.2

5.88

5.90

0.12

107

1161

(3021589) Normoblasts [#/volume] in Blood

2024

15000

1.69

57.55

13.3

9.0

0.00

e9/l

0.01

1697

12221

(3035350) Ketones [Presence] in Urine by Test strip

2167

16444

1.68

55.55

5.2

3.5

0.00

estimate

0.04

488

3276

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

248

856

3.02

54.11

2.1

2.0

10.24

11.04

mg/l

0.88

234

795

(3009261) Glucose [Presence] in Urine by Test strip

2171

16593

1.66

53.18

5.2

3.5

0.00

estimate

1.32

466

3037

(3021601) Nitrite [Presence] in Urine by Test strip

2147

16434

1.65

51.68

6.9

4.7

0.00

estimate

0.40

465

3142

(3022217) INR in Platelet poor plasma by Coagulation assay

1839

13562

1.65

51.15

14.2

13.2

1.20

1.22

inr

0.49

518

4032

(3033658) Prothrombin time (PT) actual/Normal

1214

8167

1.69

47.30

5.0

4.0

94.18

91.81

2.83

1193

7954

(3002179) Metamyelocytes/100 leukocytes in Blood

483

2439

2.11

46.49

4.9

4.0

0.73

0.65

0.14

169

754

(3017181) Myelocytes/100 leukocytes in Blood

513

2666

2.06

45.68

5.2

4.3

0.86

0.01

195

877

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

866

5354

1.78

45.39

3.9

2.7

0.98

1.23

e6/l

0.91

503

3018

(21494814) CD8 cells/100 lymphocytes in Specimen

117

6.42

44.79

2.4

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3724

33733

2.17

43.80

20.6

14.4

139.60

139.62

mmol/l

0.16

3654

32865

(3021440) Promyelocytes/100 leukocytes in Blood

488

2541

2.05

43.10

5.3

4.3

0.10

0.11

0.06

170

751

(3023103) Potassium [Moles/volume] in Serum or Plasma

3728

33840

2.15

42.67

20.7

14.5

3.94

3.95

mmol/l

1.45

3648

32898

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.43

42.44

1.1

1.4

—

(3025159) Blasts/100 leukocytes in Blood

467

2409

2.06

42.27

5.2

4.4

0.06

0.35

0.85

145

621

(3036481) Cortisol [Moles/volume] in Serum or Plasma

581

3242

1.92

42.00

2.9

2.1

377.59

369.62

nmol/l

0.21

546

2986

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

125

6.01

41.95

1.2

1.1

94.33

258.21

ng/l

0.73

(3018418) pH of Serum or Plasma

1281

8977

1.62

41.41

5.4

3.9

7.39

7.40

2.15

250

1700

(3013707) Erythrocyte sedimentation rate by Westergren method

2895

24502

1.62

41.27

4.9

4.0

12.02

11.15

mm/h

2.76

2710

22787

(3023511) Choriogonadotropin [Units/volume] in Urine

257

1046

2.55

40.80

1.6

1.3

—

(40758558) Short blood count panel - Blood

1217

8514

1.61

39.17

8.9

6.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3714

33872

2.05

38.68

19.1

13.0

22.61

22.40

mg/l

0.13

3054

26490

(3011397) Hemoglobin [Presence] in Urine by Test strip

1120

7716

1.62

38.22

4.7

3.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

6.47

37.92

1.2

18.91

16.17

0.10

(3023368) Bacteria identified in Blood by Culture

1153

8020

1.61

37.74

5.4

4.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

792

5026

1.71

36.98

4.1

2.9

3.29

2.81

e6/l

0.68

428

2706

(3009445) Proteinase 3 Ab [Units/volume] in Serum

289

1306

2.31

36.37

1.8

1.5

33.20

14.00

u/ml

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1429

10542

1.55

35.83

3.1

3.3

2.35

mmol/l

0.38

1280

9399

(3003458) Phosphate [Moles/volume] in Serum or Plasma

664

4046

1.77

35.71

7.8

6.3

1.06

mmol/l

0.19

622

3776

(3021879) Hepatitis B virus core Ab [Presence] in Serum

506

2866

1.87

34.54

1.4

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

427

2288

1.97

34.45

2.2

2.7

66.64

66.72

g/l

0.08

398

2112

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

5.71

33.44

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

240

1048

2.37

32.65

1.6

341.18

271.63

titre

0.16

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1479

11210

1.50

31.64

3.8

3.3

45.02

49.43

ng/l

0.17

971

6906

(3020779) Urea [Moles/volume] in Serum or Plasma

472

2689

1.85

31.49

9.8

8.1

9.11

9.05

mmol/l

0.06

450

2572

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

200

822

2.51

31.06

1.6

1.5

12.43

12.23

iu/ml

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

747

4869

1.65

30.93

2.0

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

193

4.21

30.12

3.6

2.8

50.98

42.92

3.39

105

(3012095) Magnesium [Moles/volume] in Serum or Plasma

756

4973

1.64

30.11

4.1

3.7

0.82

mmol/l

0.09

720

4688

(3017143) Hepatitis C virus Ab [Presence] in Serum

693

4478

1.66

29.56

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

197

4.07

28.47

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

165

651

2.60

27.90

4.4

3.7

58.76

57.01

0.86

165

651

(3002032) Base excess in Venous blood by calculation

483

2873

1.77

27.77

6.4

4.4

1.65

1.81

mmol/l

0.46

399

2373

(3021447) Carbon dioxide [Partial pressure] in Venous blood

485

2890

1.77

27.72

6.4

4.4

5.80

5.82

kpa

0.20

478

2799

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

191

4.04

27.12

1.1

—

(3012544) pH of Venous blood

493

2970

1.75

27.09

6.4

4.3

7.38

7.37

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1418

10952

1.45

26.28

4.0

3.2

33.00

33.88

u/l

0.13

1350

10423

(3008295) Osmolality of Serum or Plasma

103

328

3.20

25.81

1.5

286.81

281.57

mosm/kgh2o

1.51

249

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3801

35666

1.94

25.72

14.4

9.7

26.28

25.87

u/l

0.58

3710

34510

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1568

12430

1.42

24.83

2.0

1.9

97.09

96.31

pmol/l

0.24

852

6552

(3007164) IgA [Mass/volume] in Serum or Plasma

996

7265

1.49

24.41

1.9

1.4

2.07

2.27

g/l

4.22

641

4473

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

521

3276

1.68

24.35

8.1

7.8

4.99

5.09

kpa

1.57

493

3128

(3027801) Oxygen [Partial pressure] in Arterial blood

521

3277

1.68

24.32

8.1

7.8

13.34

12.66

kpa

1.76

492

3129

(3003396) Base excess in Arterial blood by calculation

520

3271

1.68

24.26

8.1

7.8

0.84

1.01

mmol/l

0.40

381

2577

(3037522) Nuclear Ab [Titer] in Serum

698

4752

1.57

23.50

1.4

436.15

542.49

titre

1.46

156

957

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

524

3362

1.64

22.55

1.9

1.7

—

(3000991) Gas panel - Venous blood

433

2644

1.71

22.49

11.0

8.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

627

4209

1.58

22.36

3.2

2.6

21.87

23.30

1.64

536

3646

(3007853) Bacteria identified in Skin by Aerobe culture

590

3912

1.59

22.16

2.1

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

517

3335

1.63

21.73

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3373

30967

1.51

21.43

16.5

11.7

86.87

85.36

ml/min/173m2

3.13

2853

25443

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3396

31226

1.52

21.38

5.4

4.8

1.83

2.06

mu/l

1.50

3161

28990

(3024354) Oxygen [Partial pressure] in Venous blood

394

2402

1.71

20.53

5.9

3.9

4.91

4.70

kpa

1.24

389

2321

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1266

9924

1.40

20.34

3.1

2.5

57.91

66.91

u/l

0.55

1177

9184

(3004789) Transferrin [Mass/volume] in Serum or Plasma

656

4537

1.53

20.32

3.1

2.5

2.33

2.38

g/l

1.31

610

4226

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

893

6589

1.45

20.06

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

133

555

2.44

20.05

1.5

1.7

0.54

0.76

g/l

2.26

426

(3002385) Erythrocyte distribution width [Ratio]

3249

29741

1.45

19.67

23.3

15.4

14.75

14.79

0.08

3211

29209

(40761511) CBC panel - Blood by Automated count

3748

35394

1.71

19.60

17.0

12.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

428

2702

1.65

19.51

8.9

8.5

120.71

122.37

g/l

0.91

412

2624

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2588

22811

1.37

19.51

4.0

3.0

48.41

43.88

u/l

1.68

2459

21494

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

4.19

19.30

1.1

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

316

1843

1.77

19.24

2.2

2.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

698

4943

1.50

19.23

3.1

2.5

12.53

13.63

umol/l

3.46

651

4638

(3029937) Albumin [Presence] in Urine by Test strip

1132

8777

1.40

19.16

6.4

3.8

0.00

estimate

1.49

457

3047

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

337

2007

1.74

19.07

2.6

2.2

5210.66

5355.43

u/l

0.03

805

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

134

575

2.38

19.01

1.3

1.2

125.71

237.14

titre

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1552

12694

1.36

18.81

5.7

3.6

—

(3016502) Oxygen saturation in Arterial blood

451

2914

1.62

18.70

8.6

8.3

96.49

95.78

2.71

429

2811

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

982

7467

1.41

18.50

2.0

1.9

1.33

1.13

mg/l

0.47

744

5595

(3014111) Lactate [Moles/volume] in Serum or Plasma

414

2634

1.64

18.26

9.4

7.6

1.32

1.34

mmol/l

0.14

406

2571

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2943

26627

1.38

17.83

4.7

4.1

14.74

14.61

pmol/l

2.28

2716

24487

(3021960) Folate [Moles/volume] in Serum or Plasma

912

6905

1.41

17.46

1.6

1.5

20.02

20.61

nmol/l

0.42

787

5982

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

104

4.27

17.12

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

104

4.27

17.12

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

325

2.75

17.06

4.2

4.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

736

5385

1.45

16.97

1.8

1.7

1184.34

1172.17

nmol/l

0.15

573

4114

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

324

1975

1.70

16.83

5.5

4.5

1.46

1.59

mmol/l

0.25

237

1447

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

204

3.22

16.79

2.0

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

335

2064

1.68

16.71

5.5

4.5

5.20

5.13

kpa

0.79

319

1967

(3009343) pH of Capillary blood

331

2041

1.68

16.46

5.5

4.5

7.41

0.01

219

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

494

3354

1.54

16.45

3.8

4.3

237.42

246.06

u/l

0.63

471

3181

(3021387) Prolactin [Units/volume] in Serum or Plasma

277

1628

1.75

16.40

2.1

1.6

347.81

299.05

mu/l

1.44

254

1463

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

206

1109

1.90

16.23

1.9

1.7

1.17

1.18

g/l

0.22

197

1042

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

200

1074

1.91

15.89

1.9

1.7

0.23

g/l

0.04

190

1010

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.22

15.74

2.5

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

289

1741

1.71

15.67

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

263

1545

1.75

15.60

10.2

10.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

243

1401

1.78

15.38

2.4

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

985

7697

1.37

15.31

3.2

3.1

1552.26

1340.57

ng/l

0.70

824

6500

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

106

3.99

15.02

1.2

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1050

8336

1.35

14.63

2.4

2.2

3.10

2.84

mg/l

2.89

921

7152

(40761536) Microorganisms panel - Urine sediment

429

2897

1.54

14.58

6.3

3.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

115

521

2.24

14.46

4.7

3.3

358.22

1526.77

u/ml

—

(3036489) Thrombin time

227

1312

1.77

14.25

2.5

2.7

21.20

21.47

0.41

205

1134

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

670

2.08

14.21

7.1

5.8

902.88

570.60

iu/ml

0.35

(3028192) IgG subclass 2 [Mass/volume] in Serum

345

2.52

14.20

1.5

1.4

2.73

2.87

g/l

0.28

243

(3024139) IgG subclass 3 [Mass/volume] in Serum

345

2.52

14.20

1.5

1.4

0.37

0.40

g/l

0.40

241

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

3.90

14.20

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

255

1527

1.71

14.13

10.3

10.2

24.15

24.27

mmol/l

0.26

249

1490

(3042936) Bacteria identified in Isolate by Culture

613

4473

1.44

14.13

2.4

2.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

346

2.52

14.12

1.5

1.4

6.10

6.61

g/l

0.65

244

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

530

3763

1.47

14.11

3.1

2.8

6.71

7.39

umol/l

0.39

445

3258

(4062490) Immunoglobulin typing, IgG

348

2.50

13.95

1.6

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

158

820

1.96

13.91

1.4

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

268

2.72

13.82

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

283

1754

1.66

13.79

5.9

3.6

129.72

129.41

g/l

0.08

278

1706

(3010838) Calcium [Moles/time] in 24 hour Urine

121

574

2.14

13.60

1.9

5.04

5.09

mmol/24h

0.06

111

501

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

101

3.89

13.49

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

102

453

2.28

13.47

1.7

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

208

1192

1.78

13.45

1.9

1.4

10.47

9.72

u/l

0.26

165

964

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

192

1082

1.81

13.14

3.7

3.4

3.42

3.53

g/l

0.44

186

1019

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

179

989

1.85

13.06

2.4

519.65

484.73

ug/l

0.06

166

918

(46235355) HIV 1 and 2 tests - Meaningful Use set

1001

8005

1.33

13.03

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

142

3.34

12.98

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

173

951

1.86

12.83

2.9

3.0

—

(3013512) EKG study

1045

8443

1.32

12.59

3.9

3.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

118

575

2.08

12.40

1.6

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

472

3358

1.46

12.37

3.5

2.7

1.73

1.75

0.18

423

3010

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

335

2221

1.55

12.34

1.9

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.76

12.25

2.4

2.6

27.25

29.64

umol/l

0.48

(3007930) Methemoglobin/Hemoglobin.total in Blood

193

1116

1.77

12.13

5.7

5.6

0.90

0.09

179

1038

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

194

1125

1.76

12.07

5.7

5.5

1.62

1.65

0.15

179

1044

(3022313) Gas panel - Capillary blood

247

1535

1.65

11.92

5.9

4.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

559

2.07

11.80

2.1

1.6

—

(3044889) 12 lead EKG panel

2442

22057

1.27

11.78

3.8

3.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1108

9100

1.30

11.68

5.1

3.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

132

3.28

11.61

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

225

1377

1.67

11.53

6.4

5.0

24.68

24.61

mmol/l

0.15

208

1297

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

5.25

11.53

1.3

1.2

62.00

45.73

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

435

3096

1.45

11.35

3.3

2.4

32.80

53.86

u/l

0.77

369

2670

(3044640) Blood type and Crossmatch panel - Blood

1257

10525

1.28

11.33

2.7

2.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

160

895

1.82

11.26

6.9

5.2

8.94

8.70

kpa

1.00

155

870

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

740

5770

1.34

11.24

3.8

3.5

339.97

601.73

ng/l

0.66

498

4138

(3008152) Bicarbonate [Moles/volume] in Arterial blood

272

1758

1.59

11.19

7.5

7.3

23.94

24.44

mmol/l

1.19

253

1663

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

278

1807

1.58

11.17

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3904

37861

1.69

10.99

29.2

19.1

39.99

40.24

0.91

3683

35757

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

163

924

1.80

10.99

5.2

4.4

0.36

u/ml

0.05

529

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

355

2445

1.49

10.94

5.6

3.7

1.22

1.23

mmol/l

1.01

317

2123

(3019060) Gas panel - Arterial blood

280

1832

1.57

10.93

5.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

338

2308

1.51

10.85

4.9

4.1

98.50

84.40

ng/l

1.18

300

2025

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

201

1218

1.68

10.71

1.5

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

353

2441

1.49

10.66

2.8

2.7

69.80

70.17

e9/l

0.07

264

1831

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

184

1090

1.72

10.66

2.1

1.8

—

(3010813) Leukocytes [#/volume] in Blood

3907

37921

1.68

10.65

28.9

19.0

6.83

6.74

e9/l

1.49

3823

36930

(3027273) Bicarbonate [Moles/volume] in Venous blood

217

1346

1.65

10.57

4.5

3.5

24.54

25.21

mmol/l

1.94

212

1300

(3024731) MCV [Entitic volume]

3906

37919

1.68

10.51

28.8

18.9

90.74

90.50

2.78

3866

37447

(3035941) MCH [Entitic mass]

3906

37921

1.67

10.48

28.7

18.9

30.17

0.03

3866

37445

(3007461) Platelets [#/volume] in Blood

3904

37899

1.67

10.44

28.9

19.0

258.66

256.70

e9/l

1.08

3831

37002

(3026361) Erythrocytes [#/volume] in Blood

3906

37927

1.67

10.39

28.9

19.0

4.47

4.50

e12/l

2.75

3830

36944

(3000963) Hemoglobin [Mass/volume] in Blood

3906

37939

1.66

10.22

29.1

19.1

134.07

135.03

g/l

4.14

3865

37457

(3023183) Ammonium ion [Moles/volume] in Plasma

125

668

1.90

10.19

3.0

32.11

35.90

umol/l

1.04

112

616

(1616796) Gas panel - Central venous blood

124

662

1.90

10.14

4.4

3.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1805

15925

1.24

10.00

3.3

2.9

115.95

103.36

ug/l

1.67

1681

14892

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

973

7992

1.29

10.00

2.7

2.3

—

(3012501) Base excess in Blood by calculation

127

688

1.87

9.94

5.2

4.1

2.26

2.54

mmol/l

0.50

450

(3027315) Oxygen [Partial pressure] in Blood

127

688

1.87

9.94

5.3

4.1

8.70

kpa

0.01

122

678

(3013290) Carbon dioxide [Partial pressure] in Blood

127

689

1.87

9.89

5.3

4.1

4.98

5.03

kpa

0.38

122

680

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

124

668

1.88

9.87

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

668

1.88

9.87

1.4

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

408

2946

1.43

9.82

2.4

2.3

0.22

g/l

0.41

388

2762

(3012516) Albumin [Mass/volume] in Urine

1009

8356

1.28

9.66

3.9

3.3

658.97

322.28

mg/l

1.04

654

5354

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

701

5538

1.32

9.60

2.9

2.44

mmol/l

0.23

613

4864

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.63

9.53

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

152

883

1.75

9.47

1.9

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

106

550

1.95

9.46

1.4

1.3

3.49

4.79

u/ml

0.54

244

(3010421) pH of Blood

143

818

1.78

9.40

5.3

4.0

7.41

7.42

1.99

127

738

(40761535) Cells panel - Urine sediment

357

2536

1.45

9.39

5.3

3.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

133

746

1.81

9.34

2.4

0.00

g/l

-0.00

122

695

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.51

9.29

1.2

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

132

740

1.81

9.28

2.4

0.00

g/l

-0.00

122

694

(3009508) Creatinine [Moles/volume] in Urine

1119

9426

1.26

9.22

4.0

3.3

7.30

7.62

mmol/l

1.54

967

8077

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

206

1307

1.61

9.20

1.9

1.41

1.49

g/l

0.58

177

1141

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

154

912

1.72

8.98

3.0

2.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1777

15783

1.22

8.86

2.8

2.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.33

8.86

1.2

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1044

8758

1.26

8.85

4.6

3.9

14.59

9.34

mg/mmol

1.79

679

5575

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

992

1.68

8.85

2.2

2.5

3.07

2.94

g/l

0.84

148

908

(3015171) Extractable nuclear Ab [Units/volume] in Serum

214

1384

1.58

8.83

1.3

2.28

0.65

u/ml

—

117

(3051651) Icteric interference index of Serum or Plasma

196

2.57

8.80

3.4

3.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

303

2113

1.47

8.78

2.9

2.2

11.42

12.00

nmol/l

0.56

271

1892

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

139

806

1.75

8.74

2.3

2.4

0.01

0.02

g/l

0.06

128

753

(3039000) Anion gap in Blood

114

624

1.85

8.68

6.9

7.8

11.91

11.29

mmol/l

0.77

100

551

(3018572) Chloride [Moles/volume] in Blood

114

625

1.85

8.64

6.9

7.8

105.07

105.42

mmol/l

0.24

100

552

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1053

1.65

8.63

2.1

2.5

3.47

3.65

g/l

1.05

155

969

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

976

1.68

8.63

2.2

2.5

9.58

10.44

g/l

1.71

144

886

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1054

1.65

8.60

2.1

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1054

1.65

8.60

2.1

2.5

7.47

7.30

g/l

0.59

154

969

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

487

3703

1.36

8.59

8.2

6.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3115

29357

1.26

8.57

5.9

5.2

39.55

38.98

mmol/mol

2.49

2917

27381

(3019150) Specific gravity of Urine by Refractometry

869

7162

1.27

8.51

5.7

3.8

1.02

kg/l

0.76

109

1073

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

125

713

1.78

8.34

1.7

1.5

107.54

111.76

u/ml

0.18

137

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

161

2.69

8.30

3.0

2.3

60.22

51.41

umol/l

0.99

139

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

205

1333

1.57

8.28

5.8

3.2

0.67

0.65

0.30

205

1324

(3051611) Lipemic interference index of Serum or Plasma

315

2.18

8.27

3.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

462

1.95

7.99

2.3

2.5

—

(3047181) Lactate [Moles/volume] in Blood

150

913

1.67

7.94

6.0

6.5

1.37

1.27

mmol/l

0.35

129

791

(3013005) Retinol [Moles/volume] in Serum or Plasma

171

2.59

7.91

2.1

1.87

1.84

umol/l

0.06

161

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

139

830

1.70

7.91

2.3

38.21

38.04

g/l

0.11

122

744

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

132

2.82

7.84

1.5

1152.29

405.37

mu/l

0.56

127

(40767503) Oxygen content in Capillary blood by calculation

110

616

1.81

7.82

3.0

2.4

16.30

16.28

0.02

299

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

417

3146

1.36

7.73

3.8

3.2

—

(3028433) Virus identified in Specimen by Culture

117

2.92

7.69

1.1

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

967

8155

1.24

7.66

2.9

2.6

1661.69

4347.64

umol/l

2.98

850

7223

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.52

7.64

2.1

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

327

2375

1.41

7.62

2.3

5.37

6.91

ug/l

1.54

281

2101

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

313

2257

1.42

7.60

3.1

3.3

4.52

pmol/l

0.02

284

2015

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

347

2.06

7.56

2.0

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

493

1.89

7.54

1.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

495

3850

1.33

7.48

1.7

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

431

1.94

7.47

1.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

147

905

1.65

7.47

2.3

2.5

0.24

1.00

g/l

4.67

129

804

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

136

2.74

7.43

1.5

76.08

72.73

1.09

131

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

157

986

1.62

7.37

1.2

14.66

44.84

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

119

695

1.73

7.36

1.4

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

101

562

1.82

7.36

1.4

1.2

3.18

4.43

u/ml

0.54

198

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

150

934

1.63

7.30

6.5

5.7

1.59

1.43

mg/l

1.27

136

875

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.31

7.23

1.1

1.3

112.47

121.86

nmol/l

0.15

(3020891) Body temperature

175

1134

1.57

7.21

5.9

4.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.68

7.18

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.49

7.17

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

495

1.86

7.14

2.0

1.4

69.89

64.88

mmol/l

0.45

410

(3042631) Mycobacterium sp identified in Specimen

357

2.01

7.02

4.8

2.9

—

(3024928) Oxygen saturation in Venous blood

112

654

1.73

6.95

7.4

3.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

975

8309

1.23

6.91

1.3

1.80

1.61

u/ml

0.19

241

2207

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

188

1253

1.52

6.85

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

127

773

1.66

6.78

1.7

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

136

844

1.63

6.73

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.89

6.70

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

173

1139

1.54

6.67

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

224

2.25

6.66

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

168

1101

1.55

6.62

2.2

2.0

1.58

2.25

ug/l

0.55

144

980

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

7.80

6.60

1.1

1.3

20.13

43.92

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

112

665

1.70

6.57

1.6

1.4

19.48

24.36

u/l

1.13

552

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.81

6.52

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

510

1.80

6.52

3.0

2.8

—

(3037121) Protein [Mass/volume] in Urine

167

1102

1.54

6.39

3.9

3.5

0.29

g/l

0.05

480

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3296

31552

1.23

6.26

4.5

4.1

5.86

5.82

mmol/l

0.94

3026

29064

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.40

6.13

2.0

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

390

1.89

6.11

8.1

7.1

11.00

11.42

mg/l

0.37

366

(4146454) Self-monitoring of blood glucose

293

2.03

6.09

3.0

2.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

233

2.16

6.09

1.3

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

822

1.60

6.01

3.8

3.5

32.74

71.79

mg/l

1.50

105

672

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

129

815

1.60

5.98

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

124

776

1.62

5.98

1.3

253.38

258.48

u/ml

0.08

463

(21494755) Public health laboratory ask at order entry panel

287

3816

0.73

5.95

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

401

1.86

5.94

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.01

5.89

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.40

5.85

6.4

6.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

822

1.59

5.79

3.8

3.4

76.07

59.93

mg/l

0.20

103

673

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.61

5.75

1.4

2.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

126

800

1.59

5.74

3.8

3.4

1.29

1.53

ratio

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

121

765

1.60

5.62

1.8

1.6

—

(40768446) Kidney Pathology biopsy report

133

2.49

5.60

2.2

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.74

5.60

2.5

4.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

157

1055

1.51

5.57

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

713

6005

1.23

5.55

1.3

27.70

29.39

iu/ml

0.13

177

1912

(4035726) Immunohistochemistry procedure

348

2687

1.32

5.54

1.6

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.82

5.53

1.3

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

434

1.79

5.48

1.9

1.6

—

(3016038) Potassium [Moles/volume] in Urine

191

2.21

5.46

1.7

1.3

40.91

35.07

mmol/l

0.66

174

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

570

1.68

5.43

5.5

3.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

265

2.01

5.41

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

265

2.01

5.41

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

265

2.01

5.41

1.3

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

118

749

1.59

5.40

1.9

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

321

1.91

5.39

2.4

1.60

1.57

g/24h

0.03

160

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.01

5.36

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

2.01

5.36

1.3

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

762

6484

1.22

5.34

1.7

1.6

21630533.04

33461827.56

pmol/l

0.31

638

5466

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

352

2737

1.31

5.34

1.3

1.2

162.53

162.63

iu/ml

0.00

128

1010

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

267

2.00

5.31

1.3

1.1

—

(3023419) Bacteria identified in Sputum by Culture

424

1.78

5.30

3.2

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

187

1318

1.44

5.23

1.3

—

(3017732) Neutrophils [#/volume] in Blood

310

2375

1.33

5.23

2.5

2.8

4.36

5.05

e9/l

1.11

264

1986

(3048689) Calprotectin [Mass/mass] in Stool

549

4524

1.25

5.22

2.4

134.65

116.37

ug/g

0.45

436

3603

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

215

2.11

5.20

1.8

2.8

99.04

97.13

0.15

201

(40768804) Tissue Pathology biopsy report

1499

13568

1.17

5.12

2.2

2.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

385

1.81

5.10

2.5

2.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

105

660

1.61

5.03

2.6

2.2

129.35

129.43

g/l

0.01

483

(3020961) Endomysium IgA Ab [Titer] in Serum

246

1832

1.36

5.01

1.1

65.83

145.92

titre

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

136

910

1.51

4.96

1.2

1.3

9.62

8.25

u/ml

0.07

146

(40768443) Skin Pathology biopsy report

188

1341

1.42

4.95

1.3

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.87

4.92

1.6

2.1

19.52

16.30

umol/l

0.49

(3018405) Lactate [Moles/volume] in Arterial blood

149

1020

1.48

4.87

4.6

4.1

1.34

1.40

mmol/l

0.37

144

1006

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

255

1.97

4.87

1.2

40.00

208.57

titre

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.56

4.86

1.6

1.5

1.31

1.64

mg/l

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

7.71

4.84

1.1

1.3

1.60

0.63

—

(3007566) Smooth muscle Ab [Titer] in Serum

137

924

1.50

4.82

1.3

62.50

92.82

titre

1.45

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

229

2.02

4.79

2.0

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

483

1.69

4.78

5.2

5.4

415.93

370.48

umol/l

1.90

422

(3036525) Urea [Moles/time] in 24 hour Urine

6.48

4.77

1.8

2.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

279

1.91

4.72

2.1

2.6

—

(3011648) Oxygen content in Venous blood

272

1.92

4.72

5.0

4.4

12.82

11.12

2.57

272

(3042733) HLA Ab [Presence] in Serum

114

2.47

4.70

5.5

4.7

—

(3019225) pH of Specimen

372

2970

1.28

4.64

4.8

4.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

133

900

1.49

4.62

1.4

287.35

295.64

ug/g

0.16

486

(43055514) Macroprolactin [Presence] in Serum or Plasma

103

2.53

4.62

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

306

2385

1.31

4.59

1.4

1.3

369.98

191.23

u/ml

1.00

279

2213

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

132

894

1.49

4.57

1.3

2.41

6.72

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

122

2.39

4.55

1.5

1.2

83.87

87.73

0.21

(3006653) Thiamine [Moles/volume] in Blood

173

2.15

4.55

1.4

142.59

131.96

nmol/l

0.66

173

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.53

4.55

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

4.03

2.44

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

1.46

3.47

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

0.75

1.62

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

1.66

2.05

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

1.38

1.23

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

0.56

1.12

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

3.10

3.40

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

3.46

5.66

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.39

4.43

1.6

1.5

1.73

1.69

mg/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

158

2201

0.71

4.42

1.9

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

653

1.56

4.35

4.5

2.2

0.91

0.82

nmol/l

0.57

554

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

551

1.61

4.34

2.1

1.7

—

(3000012) Reticulocyte production index

361

1.76

4.32

2.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.96

4.29

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

199

2.02

4.22

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.13

4.20

1.5

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

372

1.73

4.19

1.7

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

127

2.29

4.19

1.4

1.1

89.13

89.45

0.02

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.27

4.18

1.2

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.91

4.16

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

581

1.58

4.15

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

134

2.25

4.14

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.54

4.12

1.1

1.3

—

(3011985) Renin [Units/volume] in Plasma

404

1.69

4.12

1.5

55.86

49.81

mu/l

0.18

363

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.90

3.99

1.1

—

(36660697) Celiac disease serology panel - Serum

369

3001

1.25

3.97

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.64

3.89

1.4

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

330

1.74

3.81

4.7

5.5

6.84

7.05

mmol/l

0.21

277

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

562

1.56

3.81

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

626

1.53

3.81

3.7

3.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

8.76

3.77

6.4

4.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

401

1.66

3.72

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.63

3.65

2.0

3.4

—

(3049717) Cytology report of Urine Cyto stain

137

980

1.41

3.64

2.2

2.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

275

3428

0.79

3.58

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

1120

12324

0.87

3.57

2.8

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

532

1.55

3.55

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

105

2.29

3.52

8.9

4.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

310

2508

1.26

3.51

2.4

2.5

66.64

69.97

ml/min/173m2

0.64

126

966

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

110

762

1.46

3.49

1.3

1.2

45.29

40.64

u/ml

0.12

(3008536) Aspergillus sp Ab [Presence] in Serum

2.71

3.48

1.9

1.7

—

(3017704) Immunofixation for Urine

152

2.05

3.45

1.2

1.6

—

(3022145) Colonoscopy Study observation

418

3502

1.22

3.42

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

146

2.06

3.41

2.2

3.0

206.00

168.41

umol/l

0.11

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

121

2.16

3.31

3.0

2.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.43

3.30

9.6

10.3

5.63

6.07

mmol/l

0.27

(3000330) Specific gravity of Urine by Test strip

199

1542

1.31

3.20

4.3

3.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

143

2.04

3.20

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

260

1.74

3.10

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

159

1.96

3.08

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

543

1.50

3.07

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

543

1.50

3.07

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.84

3.02

1.0

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

409

1.57

3.01

1.8

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

271

2202

1.25

2.99

1.7

1.4

24.37

26.08

iu/l

0.36

230

1875

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

853

7667

1.14

2.96

4.8

4.7

3.68

2.77

ug/l

0.32

764

6872

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.24

2.96

2.0

3.0

178.08

153.85

ng/l

0.20

(3027923) C peptide [Moles/volume] in Serum or Plasma

169

1.90

2.94

1.5

1.26

1.28

nmol/l

0.04

132

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

146

1098

1.34

2.92

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

117

851

1.39

2.89

1.8

40.99

41.11

nmol/l

0.02

112

825

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

199

1.82

2.89

1.3

1.6

6.99

6.65

u/l

0.07

171

(1761482) Bacteria [#/volume] in Urine by Culture

100

709

1.42

2.87

6.0

4.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.34

2.81

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

393

1.56

2.79

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

137

1.98

2.79

1.1

—

(3015183) Erythrocyte sedimentation rate

219

0.36

2.78

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

159

1.89

2.75

1.9

1.6

—

(3037756) Immunofixation for Serum or Plasma

549

1.47

2.74

1.5

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

566

1.46

2.73

1.2

1.1

38.25

950.28

iu/ml

0.54

144

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

210

2611

0.79

2.73

1.4

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.01

2.72

2.6

3.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

468

1.50

2.72

1.5

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

146

1.92

2.69

1.1

1.4

139.14

158.12

mmol/24h

0.77

146

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

381

1.56

2.69

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

381

1.56

2.69

1.5

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

287

1.65

2.69

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

204

1.77

2.68

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

183

1.81

2.64

1.9

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

488

1.48

2.63

1.3

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.21

2.63

1.5

1.3

97.89

103.78

0.36

(4200892) Spirometry reversibility

269

2219

1.23

2.62

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

253

1.67

2.54

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

136

1036

1.32

2.54

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

180

1424

1.28

2.54

1.3

181.73

219.80

miu/ml

0.72

706

(3021788) Differential panel - Synovial fluid

543

1.44

2.51

1.5

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.38

2.47

1.7

4.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

129

980

1.33

2.47

1.2

—

(40768797) Stomach Pathology biopsy report

503

4412

1.16

2.47

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.14

2.44

1.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

378

4376

0.85

2.38

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

6.26

2.37

2.6

1.8

1.30

2.14

mu/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

119

901

1.33

2.34

2.2

2.0

4.79

4.38

iu/l

0.12

328

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1260

0.73

2.34

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

356

1.52

2.29

1.6

56.55

59.08

0.16

225

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

324

1.55

2.29

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

136

1054

1.30

2.28

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.56

2.27

3.3

3.5

31.58

46.28

umol/l

1.79

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

505

1.43

2.26

1.3

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

270

1.60

2.25

1.6

1.5

31.38

32.35

0.05

168

(3025941) Bacteria identified in Stool by Culture

246

2046

1.22

2.25

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

481

1.44

2.24

1.7

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

135

1049

1.30

2.23

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

383

1.50

2.22

1.3

1.4

247.37

344.56

pmol/l

2.18

338

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.34

2.21

2.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

327

1.54

2.21

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

685

1.37

2.21

1.7

1.5

0.43

0.42

nmol/l

0.03

551

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

908

8335

1.11

2.20

1.6

1.42

1.38

mmol/l

0.69

766

7101

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

143

1.82

2.18

4.8

3.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

129

1.87

2.16

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

635

5715

1.13

2.15

1.3

5.58

10.24

u/ml

2.19

219

2303

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

611

0.63

2.15

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.29

2.15

2.2

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.69

2.15

3.3

5.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.69

2.15

3.3

4.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.00

2.14

1.3

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

689

1.36

2.14

2.7

2.4

187.19

103.23

ug/min

0.56

431

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1138

0.73

2.14

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

187

1523

1.24

2.11

1.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.20

2.09

1.4

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

556

0.63

2.06

3.2

3.9

80.69

32.43

u/ml

0.67

542

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.50

2.05

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

154

1.76

2.03

1.7

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.08

2.01

7.0

3.4

—

(3044927) Protein electrophoresis panel - Urine

271

1.56

2.00

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

232

1.60

1.98

1.2

1.1

1.11

1.04

ratio

1.96

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

336

1.49

1.98

1.6

1.7

—

(3005033) Fetal Nuchal fold Thickness US

1134

0.74

1.98

1.3

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

194

1.65

1.96

1.5

1.6

5.67

5.47

u/l

0.04

165

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

1.91

1.95

2.4

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

281

1.54

1.94

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

157

1.72

1.92

1.7

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1127

0.75

1.91

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1170

0.76

1.88

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

108

1383

0.77

1.88

1.3

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

166

1.69

1.87

1.5

5.86

3.42

nmol/l

0.22

130

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

109

1390

0.78

1.84

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

109

1389

0.78

1.83

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

670

6113

1.11

1.81

4.4

4.1

22.53

21.51

0.91

306

2843

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

692

1.32

1.81

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

109

1386

0.78

1.80

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

120

1505

0.79

1.78

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

170

1.65

1.73

1.2

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

170

1.65

1.73

1.2

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

267

2303

1.17

1.69

3.1

2.9

191.15

187.79

ng/l

0.04

243

2079

(3001186) Copper [Moles/volume] in Serum or Plasma

1.91

1.69

1.8

1.4

18.80

17.57

umol/l

0.37

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

292

1.48

1.67

1.3

1.1

—

27.24

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

375

1.42

1.66

1.2

1.3

—

nmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

477

1.37

1.66

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

229

1.53

1.62

1.7

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

3.6

7.2

—

(3024932) HLA-DR beta [Type]

113

1.77

1.60

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.50

1.59

2.5

3.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

238

1.52

1.59

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.33

1.58

1.4

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

111

886

1.26

1.57

2.5

2.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

215

1.54

1.56

1.1

1.74

5.60

nmol/l

—

(3034426) Prothrombin time (PT)

130

1.70

1.52

1.5

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.34

1.52

6.8

5.8

563.60

406.47

umol/l

—

(3024471) HLA-A [Type]

115

1.74

1.52

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

395

0.63

1.51

1.2

1.6

7.36

7.61

mmol/l

0.40

380

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

198

2318

0.85

1.51

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.16

1.50

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

410

3683

1.13

1.48

4.5

4.2

31.51

32.29

0.79

313

2577

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

227

1.50

1.46

2.1

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

377

1.38

1.46

1.2

—

(4212803) Bone marrow aspirate examination

2.50

1.45

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.13

1.44

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

142

1700

0.83

1.41

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

597

1.30

1.40

2.1

1.9

168.32

196.75

pmol/l

1.58

558

(3024869) Neuronal Ab [Presence] in Serum

2.18

1.39

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

120

1457

0.82

1.38

1.7

5.80

4.27

mg/l

0.43

1055

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

364

1.38

2.5

2.2

21.00

23.02

mg/l

0.14

(3045142) Bone marrow Pathology biopsy report

339

1.39

1.37

1.4

—

(3045424) Erythrocytes [Presence] in Urine

555

1.30

1.37

2.0

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

119

1.68

1.37

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

119

1.68

1.37

1.6

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

970

0.78

1.37

1.4

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.61

1.36

1.2

1.3

—

(3008607) Semen analysis panel

2.94

1.36

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

796

1.25

1.36

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

150

1260

1.20

1.35

1.8

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

592

1.29

1.35

1.9

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

232

1.47

1.34

1.4

70.74

79.52

umol/l

1.78

232

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.50

1.30

1.0

0.01

0.23

u/ml

—

(3022621) pH of Urine by Test strip

245

2150

1.15

1.30

3.2

2.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

201

1.50

1.29

1.2

1.5

8.39

7.96

ug/l

0.07

173

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.09

1.27

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

370

1.36

1.27

1.4

1.2

—

31.57

—

(3009871) Measles virus Ab [Titer] in Serum

122

1.64

1.27

1.6

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

252

2220

1.14

1.27

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3347

32957

1.09

1.26

4.8

4.4

2.74

2.80

mmol/l

3.16

3110

30726

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

295

1.39

1.24

3.0

2.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

723

6754

1.09

1.23

1.5

—

(3022670) pH of Venous cord blood

2.31

1.18

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

222

1.44

1.18

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

149

1.55

1.17

1.9

2.2

—

(3006462) Nitrate [Presence] in Urine

149

1.55

1.17

3.8

3.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

120

1004

1.20

1.16

3.0

3.5

51.24

4180.28

u/ml

0.87

854

(3036180) Methadone [Presence] in Urine

190

1.48

1.16

1.2

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

750

1.23

1.15

2.3

2.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.81

1.15

1.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

589

1.26

1.14

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

224

1.43

1.14

1.1

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

167

1.50

1.12

2.9

2.1

25.00

29.06

umol/l

1.75

162

(3019977) pH of Arterial blood

151

1.53

1.11

1.7

3.1

7.40

7.43

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.71

1.11

1.5

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.71

1.11

1.5

3.0

—

(3011288) Drugs identified in Urine by Screen method

140

1194

1.18

1.11

2.5

2.9

—

(3030313) Adrenal Ab [Titer] in Serum

1.95

1.08

1.4

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

269

1.38

1.08

4.9

3.9

—

(3044009) aPTT.lupus sensitive (LA screen)

2.06

1.02

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.84

1.02

1.7

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

138

1.52

1.02

1.0

1.1

—

(3003338) MCHC [Mass/volume]

3016

29663

1.06

1.00

24.9

16.3

331.95

332.57

g/l

3.35

2998

29439

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.18

0.98

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

260

0.65

0.97

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

116

1.55

0.96

2.7

2.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

159

1.45

0.91

1.1

1.3

283.74

391.94

u/l

0.51

145

(3008898) HLA-B27 [Presence]

163

1436

1.14

0.89

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

566

1.22

0.87

1.9

1.7

—

(3042517) Benzodiazepines panel - Urine

1.86

0.87

1.5

2.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

0.87

1.5

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3290

32493

1.06

0.86

4.3

4.0

4.62

4.70

mmol/l

4.59

3078

30477

(3035285) Chloride [Moles/volume] in Venous blood

334

1.29

0.86

2.9

2.5

105.12

105.55

mmol/l

0.20

329

(3041354) Potassium [Moles/volume] in Venous blood

334

1.29

0.86

2.9

2.5

4.02

4.04

mmol/l

0.10

329

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

1.46

0.84

3.3

2.5

—

(3016750) Collection duration of Urine

180

1.39

0.81

2.6

2.3

509.05

496.07

min

0.44

133

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.65

0.81

1.7

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

117

1344

0.87

0.81

1.9

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

285

1.30

0.80

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

164

1.40

0.79

1.9

1.7

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.62

0.78

2.1

2.0

1.33

1.72

mmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

187

0.64

0.78

1.2

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

243

1.32

0.77

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

379

4068

0.92

0.76

1.7

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

270

1.30

0.75

1.4

1.3

2.09

2.80

u/ml

0.24

143

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

812

7758

1.06

0.75

1.7

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

725

1.18

0.74

1.6

1.7

7487.45

12962.69

e6/l

1.78

528

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.08

0.74

1.2

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.84

0.73

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.84

0.73

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.00

0.72

1.4

1.6

303.00

322.32

umol/24h

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

326

1.26

0.71

3.0

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

134

1.42

0.71

2.0

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

1.58

0.71

1.4

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

312

2892

1.09

0.71

3.6

4.1

34.18

18.30

ug/l

0.23

250

2297

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

247

1.30

0.70

1.4

1.2

—

(1002224) Polysomnography panel

157

1408

1.12

0.69

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

292

1.27

0.69

1.3

1.4

—

titre

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

135

1.41

0.69

2.1

1.8

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.60

0.68

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.60

0.68

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.60

0.68

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

1.60

0.68

1.5

3.75

0.63

mmol/l

1.63

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.60

0.68

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

363

0.77

0.67

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

1.63

0.66

1.4

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

466

1.20

0.66

1.2

30.29

43.90

u/l

0.65

401

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.79

0.66

11.6

8.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.79

0.66

2.0

3.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

250

1.28

0.65

1.4

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

103

1.46

0.65

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

233

1.29

0.64

2.6

2.3

672.91

602.90

0.56

157

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

201

0.70

0.64

1.3

1.1

—

(3047189) Immunofixation for 24 hour Urine

129

1.40

0.63

1.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

164

1.34

0.62

1.9

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.67

0.61

1.6

1.3

—

6.32

mmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

412

4365

0.94

0.61

1.8

1.53

1.42

1.65

365

3879

(3002256) Pathology report gross observation

449

4247

1.06

0.61

1.3

—

(40768793) Breast Pathology biopsy report

781

0.86

0.61

1.3

—

(3035880) pH of Pleural fluid

139

0.65

0.60

1.2

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.57

0.60

1.6

1.4

—

(44813793) Dust mix specific IgE antibody measurement

254

1.26

0.59

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

172

1569

1.10

0.58

2.2

2.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

2.6

—

(3019174) dRVVT (LA screen)

1.72

0.57

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

285

0.77

0.55

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

133

1.35

0.55

1.0

8.67

13.69

u/ml

—

(3004451) EKG impression Narrative

133

1.35

0.55

1.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

498

4746

1.06

0.54

1.6

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.58

0.54

1.0

—

(40768795) Lymph node Pathology biopsy report

294

1.23

0.54

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

1.34

0.53

2.1

1.8

—

(3017569) Oxygen content in Arterial blood

134

1.34

0.53

2.1

2.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

295

1.22

0.52

2.0

21.22

23.39

ug/l

0.15

290

(21494434) Karyotype in Bone marrow

268

1.23

0.52

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

260

0.77

0.52

1.3

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

651

0.86

0.52

2.2

2.3

5.24

6.38

umol/l

0.62

481

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.50

0.51

1.3

2.0

1.02

1.33

mg/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

224

1.25

0.50

1.3

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.46

0.50

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.46

0.50

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

690

1.13

0.48

1.6

1.8

—

(3035933) Granulocytes/100 leukocytes in Blood

155

0.71

0.48

1.1

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

234

0.77

0.48

13.4

12.6

731.50

850.37

nmol/l

0.42

225

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

464

4436

1.05

0.47

3.1

3.0

0.74

ug/l

0.01

301

2846

(3001556) Androgen free Index in Serum or Plasma

1.46

0.46

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

684

1.13

0.45

1.4

2.33

3.94

ug/l

2.55

631

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

449

1.16

0.45

1.1

1.48

1.49

g/l

0.12

405

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.40

0.45

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

164

0.73

0.45

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

810

0.89

0.44

1.1

8.13

6.25

u/ml

0.27

460

(3039443) Prostate specific Ag panel - Serum or Plasma

470

0.85

0.44

1.6

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

128

0.70

0.43

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3253

32284

1.04

0.42

4.3

4.0

1.44

1.48

mmol/l

4.01

3019

30127

(3020491) Glucose [Moles/volume] in Blood

249

1.21

0.41

1.6

1.9

6.54

6.51

mmol/l

0.02

178

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.52

0.41

2.8

2.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

710

1.11

0.40

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

168

1.25

0.40

2.2

1.7

1.07

4.02

u/field

1.46

122

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

241

1.20

0.40

3.1

2.2

3.70

1.88

u/field

—

104

(3000492) Spirometry study

353

3371

1.05

0.39

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

270

1.19

0.38

1.3

1.1

18.27

1.84

u/ml

0.64

(3028717) Thiamine [Mass/volume] in Blood

1.39

0.38

1.2

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.34

0.38

1.4

1.2

0.87

73.64

mg/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

236

0.80

0.38

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

781

1.10

0.37

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3136

31128

1.03

0.37

3.9

3.6

1.32

1.27

mmol/l

3.34

2909

28872

(3035320) C reactive protein [Mass/volume] in Body fluid

244

1.19

0.36

2.3

2.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.66

0.35

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.36

0.34

1.8

1.5

96.50

134.21

ng/l

—

(40768800) Prostate Pathology biopsy report

457

0.87

0.33

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

136

1.25

0.33

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

265

1.17

0.33

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

387

1.14

0.33

1.9

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

388

1.14

0.32

1.9

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.35

0.32

1.4

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.35

0.32

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

202

1914

1.06

0.32

2.7

3.1

56.01

47.31

u/ml

0.14

196

1845

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

543

5598

0.97

0.32

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

165

0.79

0.32

2.0

1.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

390

1.13

0.30

1.9

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

207

0.82

0.30

1.4

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

203

1.18

0.29

1.0

1.4

160.80

206.31

pmol/l

0.45

203

(3020191) Ethanol [Moles/volume] in Serum or Plasma

259

1.16

0.29

1.4

1.5

1.36

1.28

promille

0.10

202

(3003740) Influenza virus B Ag [Presence] in Specimen

650

0.91

0.29

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

487

5018

0.97

0.29

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

392

1.12

0.29

1.9

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

323

0.87

0.28

1.3

1.5

1197.29

2292.17

e6/l

1.30

229

(3037692) Legionella sp identified in Specimen by Organism specific culture

103

1.26

0.28

2.6

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.29

0.28

1.6

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

479

1.11

0.28

4.1

3.1

0.76

0.82

nmol/l

0.54

368

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.25

0.27

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

394

1.12

0.27

1.9

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

687

0.92

0.26

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.26

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

582

0.91

0.25

1.4

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

123

1.22

0.25

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

114

1.23

0.25

5.4

12.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

777

0.93

0.24

1.1

1.94

1.17

u/ml

0.22

371

(3027944) Amphetamines [Presence] in Urine

163

1711

0.95

0.24

2.3

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.17

0.24

8.2

5.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

651

0.92

0.23

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

630

1.08

0.23

1.1

5.60

4.11

u/ml

0.32

316

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

399

1.10

0.23

1.9

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.28

0.23

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

109

1029

1.06

0.22

1.1

1.22

5.26

u/ml

2.53

142

(3015076) Soybean IgE Ab [Units/volume] in Serum

247

1.13

0.22

1.1

0.15

3.54

u/ml

0.92

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.22

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.25

0.22

2.8

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.27

0.22

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.22

0.22

7.0

7.6

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.22

0.22

1.0

163.40

163.17

g/l

—

(3028300) Cannabinoids [Presence] in Urine

167

1744

0.96

0.21

2.3

2.1

—

(3012441) Differential panel - Pleural fluid

267

1.12

0.21

1.1

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

446.69

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.58

—

(40765096) Chromosome analysis panel by Banding

1.23

0.21

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

283

0.88

0.21

1.4

30410.28

79127.30

e6/l

0.60

195

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

105

0.76

0.21

1.0

1.4

15.02

8.53

ug/l

—

105

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.22

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.01

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

316

1.11

0.20

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.25

0.20

1.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

278

1.12

0.20

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

278

1.12

0.20

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

278

1.12

0.20

1.7

1.6

—

(3027008) Opiates [Presence] in Urine

167

1740

0.96

0.20

2.3

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

577

1.08

0.20

1.1

7.29

4.19

u/ml

0.44

249

(1001926) Buprenorphine [Presence] in Urine by Screen method

142

1358

1.05

0.19

2.5

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

587

1.07

0.19

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.20

0.19

1.2

1.8

26.57

34.15

pmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

201

2081

0.96

0.18

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

175

1.14

0.18

1.1

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

1.17

0.18

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

271

1.11

0.18

1.1

0.39

2.53

u/ml

1.24

108

(3024263) Appearance of Synovial fluid

157

1.15

0.17

1.2

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

224

1.12

0.17

1.1

1.3

1.58

g/l

0.01

224

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.11

0.17

1.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.75

0.17

1.0

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

288

0.90

0.16

1.3

1.4

71340.58

80526.01

e6/l

0.06

170

(3051387) C reactive protein [Mass/volume] in Capillary blood

693

1.05

0.14

3.5

26.05

25.75

mg/l

0.03

435

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

347

3399

1.02

0.14

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

139

1437

0.97

0.13

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

127

0.87

0.12

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

531

1.06

0.12

1.1

2.10

0.28

u/ml

0.63

170

(3000764) Benzodiazepines [Presence] in Urine

168

1725

0.97

0.11

2.3

2.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

337

1.07

0.11

1.3

1.5

28.87

32.45

g/l

1.11

304

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2470

24603

1.01

0.11

3.4

3.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

239

0.92

0.10

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

173

1.10

0.10

1.0

864.21

719.75

ng/l

0.48

109

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

141

1448

0.97

0.10

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

566

0.95

0.10

1.1

1.93

3.62

u/ml

1.14

280

(3010726) Horse dander IgE Ab [Units/volume] in Serum

759

0.96

0.10

1.1

3.91

1.66

u/ml

0.48

408

(4281824) Cell count and differential, peritoneal fluid

351

0.94

0.10

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

798

0.96

0.09

1.3

1.2

—

(4034850) Laboratory test

109

1059

1.03

0.09

11.8

9.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

137

1336

1.03

0.09

1.7

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

213

1.08

0.09

4.0

6.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.04

0.09

1.8

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

155

1.10

0.09

1.0

1.1

4.47

6.88

u/ml

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

214

1.08

0.08

1.2

1.4

6.40

5.58

mmol/l

0.54

204

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

175

1.09

0.08

1.0

40.75

44.41

ng/l

0.17

109

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.77

0.08

1.0

1.1

86.50

72.03

ug/l

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.14

0.08

1.2

1.3

0.75

1.19

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

154

0.91

0.08

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.04

0.08

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.04

0.08

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.04

0.08

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

137

1.10

0.07

1.5

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.07

0.07

1.1

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.05

0.07

3.1

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.05

0.07

1.6

3.0

—

(3003694) ABO and Rh group [Type] in Blood

1018

10237

0.99

0.07

1.6

—

(3022689) Creatine [Moles/volume] in Urine

1.02

0.07

1.3

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

140

1.07

0.04

1.1

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

281

0.96

0.04

1.6

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

131

1.07

0.03

2.6

3.1

—

(3014271) Vancomycin [Susceptibility]

131

1.07

0.03

3.5

2.8

—

(3006598) pH of Arterial cord blood

102

1.08

0.03

1.0

—

(3044941) Cell count panel - Synovial fluid

490

1.02

0.02

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

205

2064

0.99

0.02

1.3

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

113

1.06

0.01

1.6

1.2

—

(3016879) Cocaine [Presence] in Urine

162

1610

1.01

0.01

2.3

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

177

0.96

0.01

1.4

1.2

—

(40768441) Liver Pathology biopsy report

247

0.97

0.01

1.4

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

174

1.03

0.00

1.0

305.15

306.26

ng/l

0.01

112

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

276

0.98

0.00

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

276

0.98

0.00

1.3

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

115

0.96

0.00

1.0

20.16

19.88

mmol/l

0.16

108

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

358

1.01

0.00

3.0

4.5

23.86

77.16

u/ml

—

107

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

888

1.00

0.00

1.2

1.1

2.80

2.49

u/ml

0.14

490

(3038177) Helicobacter pylori Ab [Presence] in Serum

615

0.99

0.00

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

1.01

0.00

3.2

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

101

0.99

0.00

3.0

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

359

1.00

0.00

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

889

1.00

0.00

1.6

1.5

136.83

159.74

pmol/l

0.22

870

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

346

1.01

0.00

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

265

2647

1.00

0.00

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

257

1.01

0.00

1.1

10.75

9.74

iu/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

577

1.01

0.00

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.7

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.38

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1026.00

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.01

-0.00

6.0

5.9

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

2.30

—

(3048879) Bone marrow aspiration report

0.99

-0.00

2.5

1.9

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

6.8

—

79.00

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.24

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.94

-0.00

1.4

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

18.23

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.91

-0.00

1.0

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

2.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.99

-0.00

1.0

1.1

0.50

3.85

u/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.90

-0.00

1.0

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

68.80

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

34.94

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.89

-0.00

1.4

1.7

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1296.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_OPTNERVE and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_OPTNERVE	1.564 [1.39, 1.75]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.218

During the follow-up period (1.1.1998 — 31.12.2019), 1571 out of 11910 females with H7_OPTNERVE died.

Males

Parameter	HR [95% CI]	p-value
H7_OPTNERVE	1.746 [1.56, 1.95]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1787 out of 8355 males with H7_OPTNERVE died.

Mortality risk

Mortality risk for people of age

years, who have H7_OPTNERVE.

N-year risk	Females	Males
1	0.211%	0.338%
5	0.888%	2.093%
10	2.284%	4.916%
15	4.457%	9.159%
20	7.639%	15.306%

Relationships between endpoints

↥

Index endpoint: H7_OPTNERVE – Disorders of optic nerve and visual pathways

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of optic nerve and visual pathways

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints